0001956955 2026-01-01 2026-06-30 0001956955 2026-08-06 0001956955 2026-06-30 0001956955 2025-12-31 0001956955 2026-04-01 2026-06-30 0001956955 2025-04-01 2025-06-30 0001956955 2025-01-01 2025-06-30 0001956955 us-gaap:CommonStockMember 2024-12-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001956955 us-gaap:RetainedEarningsMember 2024-12-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001956955 2024-12-31 0001956955 us-gaap:CommonStockMember 2025-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001956955 us-gaap:RetainedEarningsMember 2025-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001956955 2025-03-31 0001956955 us-gaap:CommonStockMember 2025-12-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001956955 us-gaap:RetainedEarningsMember 2025-12-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001956955 us-gaap:CommonStockMember 2026-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001956955 us-gaap:RetainedEarningsMember 2026-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001956955 2026-03-31 0001956955 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001956955 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001956955 2025-01-01 2025-03-31 0001956955 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001956955 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001956955 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001956955 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001956955 2026-01-01 2026-03-31 0001956955 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001956955 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0001956955 us-gaap:CommonStockMember 2025-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001956955 us-gaap:RetainedEarningsMember 2025-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001956955 2025-06-30 0001956955 us-gaap:CommonStockMember 2026-06-30 0001956955 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001956955 us-gaap:RetainedEarningsMember 2026-06-30 0001956955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001956955 2025-01-01 2025-12-31 0001956955 UMAC:WarrantLiabilityMember 2026-06-30 0001956955 UMAC:WarrantLiabilityMember 2025-12-31 0001956955 us-gaap:GeographicDistributionForeignMember 2026-01-01 2026-06-30 0001956955 us-gaap:GeographicDistributionForeignMember 2025-01-01 2025-06-30 0001956955 UMAC:ShippingAndHandlingCostsMember 2026-01-01 2026-06-30 0001956955 UMAC:ShippingAndHandlingCostsMember 2025-01-01 2025-06-30 0001956955 UMAC:CommonStockInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:CommonStockInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:CommonStockInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:CommonStockInvestmentMember 2026-06-30 0001956955 UMAC:PreFundedWarrantsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:PreFundedWarrantsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:PreFundedWarrantsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:PreFundedWarrantsMember 2026-06-30 0001956955 UMAC:WarrantsInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:WarrantsInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:WarrantsInvestmentMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:WarrantsInvestmentMember 2026-06-30 0001956955 UMAC:TotalShortTermInvestmentsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:TotalShortTermInvestmentsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:TotalShortTermInvestmentsMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:TotalShortTermInvestmentsMember 2026-06-30 0001956955 UMAC:RotorLabContingentConsiderationMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel1Member UMAC:RotorLabContingentConsiderationMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel2Member UMAC:RotorLabContingentConsiderationMember 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:RotorLabContingentConsiderationMember 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputSharePriceMember 2026-01-01 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputQuotedPriceMember 2026-01-01 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:WarrantsInvestmentMember 2025-12-31 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:WarrantsInvestmentMember 2026-01-01 2026-06-30 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:RotorLabContingentConsiderationMember 2025-12-31 0001956955 us-gaap:FairValueInputsLevel3Member UMAC:RotorLabContingentConsiderationMember 2026-01-01 2026-06-30 0001956955 UMAC:PublicCommonStockMember 2025-12-31 0001956955 UMAC:PublicCommonStockMember 2026-01-01 2026-06-30 0001956955 UMAC:PublicCommonStockMember 2026-06-30 0001956955 UMAC:PublicPreFundedWarrantsMember 2025-12-31 0001956955 UMAC:PublicPreFundedWarrantsMember 2026-01-01 2026-06-30 0001956955 UMAC:PublicPreFundedWarrantsMember 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember 2025-12-31 0001956955 UMAC:NonPublicWarrantsMember 2026-01-01 2026-06-30 0001956955 UMAC:NonPublicWarrantsMember 2026-06-30 0001956955 UMAC:PubliclyHeldInvestmentsMember 2025-12-31 0001956955 UMAC:PubliclyHeldInvestmentsMember 2026-01-01 2026-06-30 0001956955 UMAC:PubliclyHeldInvestmentsMember 2026-06-30 0001956955 us-gaap:CommonStockMember 2026-06-30 0001956955 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001956955 us-gaap:PreferredStockMember 2026-06-30 0001956955 us-gaap:PreferredStockMember 2026-01-01 2026-06-30 0001956955 UMAC:CommonAndPreferredStockMember 2026-06-30 0001956955 UMAC:CommonAndPreferredStockMember 2026-01-01 2026-06-30 0001956955 UMAC:RetailRevenueMember 2026-01-01 2026-06-30 0001956955 UMAC:RetailRevenueMember 2025-01-01 2025-06-30 0001956955 UMAC:EnterpriseRevenueMember 2026-01-01 2026-06-30 0001956955 UMAC:EnterpriseRevenueMember 2025-01-01 2025-06-30 0001956955 UMAC:RetailRevenueMember 2026-04-01 2026-06-30 0001956955 UMAC:RetailRevenueMember 2025-04-01 2025-06-30 0001956955 UMAC:EnterpriseRevenueMember 2026-04-01 2026-06-30 0001956955 UMAC:EnterpriseRevenueMember 2025-04-01 2025-06-30 0001956955 UMAC:UnvestedStockOptionsMember 2026-04-01 2026-06-30 0001956955 UMAC:UnvestedStockOptionsMember 2025-04-01 2025-06-30 0001956955 UMAC:UnvestedRestrictedStockWarrantsMember 2026-04-01 2026-06-30 0001956955 UMAC:UnvestedRestrictedStockWarrantsMember 2025-04-01 2025-06-30 0001956955 UMAC:RepresentativeWarrantsMember 2026-04-01 2026-06-30 0001956955 UMAC:RepresentativeWarrantsMember 2025-04-01 2025-06-30 0001956955 UMAC:PIPEWarrantsMember 2026-04-01 2026-06-30 0001956955 UMAC:PIPEWarrantsMember 2025-04-01 2025-06-30 0001956955 UMAC:RotorLabMember us-gaap:CommonStockMember UMAC:RotorLabPurchaseAgreementMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember UMAC:ContingentSharesMember UMAC:RotorLabPurchaseAgreementMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember 2025-09-01 2025-09-03 0001956955 UMAC:RotorLabMember 2025-09-03 0001956955 UMAC:RotorLabMember 2026-06-30 0001956955 UMAC:RotorLabMember 2025-09-03 0001956955 UMAC:RotorLabMember 2025-09-04 2025-12-31 0001956955 UMAC:RotorLabMember 2025-01-01 2025-12-31 0001956955 srt:ProFormaMember UMAC:RotorLabMember 2025-01-01 2025-12-31 0001956955 UMAC:RotorLabMember 2024-01-01 2024-12-31 0001956955 srt:ProFormaMember UMAC:RotorLabMember 2024-01-01 2024-12-31 0001956955 UMAC:PrepaidInsuranceMember 2026-06-30 0001956955 UMAC:PrepaidInsuranceMember 2025-12-31 0001956955 UMAC:PrepaidBenefitsMember 2026-06-30 0001956955 UMAC:PrepaidBenefitsMember 2025-12-31 0001956955 UMAC:PrepaidOtherMember 2026-06-30 0001956955 UMAC:PrepaidOtherMember 2025-12-31 0001956955 UMAC:RentSecurityDepositsMember 2026-06-30 0001956955 us-gaap:ComputerEquipmentMember 2026-06-30 0001956955 us-gaap:ComputerEquipmentMember 2025-12-31 0001956955 us-gaap:EquipmentMember 2026-06-30 0001956955 us-gaap:EquipmentMember 2025-12-31 0001956955 us-gaap:OfficeEquipmentMember 2026-06-30 0001956955 us-gaap:OfficeEquipmentMember 2025-12-31 0001956955 UMAC:TenantImprovementsMember 2026-06-30 0001956955 UMAC:TenantImprovementsMember 2025-12-31 0001956955 UMAC:MotorEquipmentMember 2026-06-30 0001956955 UMAC:TenantImprovementsMember 2026-06-30 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2024-02-16 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2026-01-01 2026-06-30 0001956955 UMAC:OrlandoFloridaMember UMAC:RotorRiotMember 2025-01-01 2025-06-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2025-08-01 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2026-01-01 2026-06-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:June2025AdditionalSpaceMember 2025-01-01 2025-06-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2025-12-01 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2026-01-01 2026-06-30 0001956955 UMAC:OrlandoFLMember UMAC:RotorRiotMember UMAC:October2025AdditionalSpaceMember 2025-01-01 2025-06-30 0001956955 UMAC:OrlandoFL1Member 2026-01-02 0001956955 UMAC:OrlandoFL1Member 2026-01-01 2026-06-30 0001956955 UMAC:OrlandoFL1Member 2025-01-01 2025-06-30 0001956955 UMAC:OrlandoFL2Member 2026-02-01 0001956955 UMAC:OrlandoFL2Member 2026-01-01 2026-06-30 0001956955 UMAC:OrlandoFL2Member 2025-01-01 2025-06-30 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2025-09-03 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2026-01-01 2026-06-30 0001956955 UMAC:CanberraAustraliaMember UMAC:RotorRiotMember 2025-01-01 2025-06-30 0001956955 UMAC:Year2026Member 2026-06-30 0001956955 UMAC:Year2027Member 2026-06-30 0001956955 UMAC:Year2028Member 2026-06-30 0001956955 UMAC:Year2029Member 2026-06-30 0001956955 UMAC:Year2030Member 2026-06-30 0001956955 UMAC:UMACMember 2026-06-30 0001956955 UMAC:RotorRiotMember 2026-06-30 0001956955 us-gaap:PatentsMember 2026-06-30 0001956955 UMAC:RotorLabMember 2026-06-30 0001956955 us-gaap:CustomerRelationshipsMember 2026-06-30 0001956955 us-gaap:NoncompeteAgreementsMember 2026-06-30 0001956955 us-gaap:TrademarksMember 2026-06-30 0001956955 us-gaap:TradeNamesMember 2026-06-30 0001956955 UMAC:EmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:January2026IssuanceMember 2026-01-01 2026-01-02 0001956955 UMAC:ExecutiveOfficersMember UMAC:EquityIncentivePlan2022Member UMAC:January232026IssuanceMember 2026-01-22 2026-01-23 0001956955 UMAC:CertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:January232026IssuanceMember 2026-01-22 2026-01-23 0001956955 UMAC:CertainBoardMembersMember 2026-03-12 2026-03-13 0001956955 UMAC:CertainBoardMembersMember 2026-05-19 2026-05-20 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:January2026IssuanceMember 2026-01-01 2026-01-02 0001956955 UMAC:CommonSharesIssuedForServicesMember 2026-05-21 2026-05-22 0001956955 UMAC:SeveralEmployeesMember 2026-01-01 2026-06-30 0001956955 2026-01-08 2026-01-09 0001956955 UMAC:PublicOfferingMember 2026-03-18 2026-03-19 0001956955 UMAC:PublicOfferingMember UMAC:PlacementAgentFeesMember 2026-03-18 2026-03-19 0001956955 UMAC:PublicOfferingMember UMAC:OtherOfferingExpensesMember 2026-03-18 2026-03-19 0001956955 UMAC:AtTheMarketOfferingMember 2026-05-28 2026-05-29 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:January2025IssuanceMember 2025-01-13 2025-01-14 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:January2025IssuanceMember 2026-01-13 2026-01-14 0001956955 UMAC:ExecutiveOfficersAndCertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:February2025IssuanceMember 2025-02-02 2025-02-03 0001956955 UMAC:ExecutiveOfficersAndCertainEmployeesMember UMAC:EquityIncentivePlan2022Member UMAC:February2025IssuanceMember 2025-01-01 2025-12-31 0001956955 UMAC:WarrantExercisesMember us-gaap:CommonStockMember 2025-02-01 2025-02-28 0001956955 2025-02-01 2025-02-28 0001956955 UMAC:PublicOfferingMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember UMAC:PlacementAgentFeesMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember UMAC:OtherOfferingExpensesMember 2025-05-05 2025-05-06 0001956955 UMAC:PublicOfferingMember 2025-05-06 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-05-18 2025-05-19 0001956955 UMAC:NonEmployeeDirectorsMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-01-01 2025-06-30 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-05-18 2025-05-19 0001956955 UMAC:ConsultantMember UMAC:EquityIncentivePlan2022Member UMAC:May2025IssuanceMember 2025-01-01 2025-06-30 0001956955 UMAC:AdvisoryBoardMembersMember 2025-05-21 2025-05-22 0001956955 UMAC:AdvisoryBoardMembersMember 2026-05-21 2026-05-22 0001956955 UMAC:SeveralEmployeesMember 2025-01-01 2025-06-30 0001956955 srt:ChiefExecutiveOfficerMember UMAC:EquityIncentivePlan2022Member 2025-06-29 2025-06-30 0001956955 UMAC:EquityIncentivePlan2022Member 2026-01-01 2026-06-30 0001956955 UMAC:CertainEmployeesMember us-gaap:StockOptionMember 2026-01-01 2026-06-30 0001956955 UMAC:CertainEmployeesMember us-gaap:StockOptionMember 2025-01-01 2025-06-30 0001956955 us-gaap:StockOptionMember 2026-01-01 2026-06-30 0001956955 us-gaap:StockOptionMember 2025-01-01 2025-06-30 0001956955 UMAC:UnvestedStockOptionsMember 2026-06-30 0001956955 us-gaap:RestrictedStockMember 2026-01-01 2026-06-30 0001956955 us-gaap:RestrictedStockMember 2025-01-01 2025-06-30 0001956955 UMAC:UnvestedRestrictedStockMember 2026-06-30 0001956955 us-gaap:StockOptionMember 2025-12-31 0001956955 us-gaap:StockOptionMember 2025-01-01 2025-12-31 0001956955 us-gaap:StockOptionMember 2026-06-30 0001956955 srt:MinimumMember us-gaap:StockOptionMember 2026-06-30 0001956955 srt:MaximumMember us-gaap:StockOptionMember 2026-06-30 0001956955 srt:MinimumMember us-gaap:StockOptionMember 2026-01-01 2026-06-30 0001956955 srt:MaximumMember us-gaap:StockOptionMember 2026-01-01 2026-06-30 0001956955 us-gaap:RestrictedStockMember 2025-12-31 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-06-30 0001956955 us-gaap:RestrictedStockMember 2026-06-30 0001956955 us-gaap:RestrictedStockUnitsRSUMember 2026-06-30 0001956955 UMAC:DrEvansMember 2023-12-04 2025-10-31 0001956955 UMAC:DrEvansMember 2025-11-01 2026-03-31 0001956955 UMAC:DrEvansMember 2026-04-01 2026-04-02 0001956955 UMAC:IndependentDirector1Member 2026-03-12 2026-03-13 0001956955 UMAC:IndependentDirector2Member 2026-03-12 2026-03-13 0001956955 UMAC:IndependentDirector3Member 2026-03-12 2026-03-13 0001956955 2026-03-12 2026-03-13 0001956955 UMAC:CEOAndTwoIndependentDirectorsMember 2026-03-30 2026-04-02 0001956955 UMAC:TealDronesMember 2026-01-01 2026-01-31 0001956955 UMAC:TealDronesMember 2026-01-01 2026-06-30 0001956955 UMAC:TealDronesMember 2026-06-30 0001956955 UMAC:WarehouseAndOfficeSpaceMember 2024-02-13 2024-02-14 0001956955 UMAC:DroneMotorManufacturingFacilityMember 2025-06-03 2025-06-04 0001956955 UMAC:OfficeSpaceMember 2025-10-29 2025-10-30 0001956955 UMAC:CorporateHeadquartersMember 2025-12-09 2025-12-10 0001956955 UMAC:HeadsetProductionMember 2025-12-14 2025-12-15 0001956955 UMAC:AllanEvansMember 2025-07-01 2025-09-30 iso4217:USD shares iso4217:USD shares pure UMAC:Integer false 2026 Q2 --12-31 0001956955 1 10-Q true 2026-06-30 false 001-41961 Unusual Machines, Inc. NV 66-0927642 5728 Major Blvd Suite 250 Orlando FL 32819 720 383-8983 Common Stock, par value $0.01 per share UMAC NYSE Yes Yes Non-accelerated Filer true true false false 49956505 229598776 103261397 39273449 39214909 47500000 0 9333235 1564739 1278160 214684 21914332 5316648 20543732 9748483 1134261 190622 370575945 159511482 2711375 2233891 3090057 2607256 3067056 197785 15596105 15596105 2452610 2561895 26917203 23196932 397493148 182708414 2863569 1506793 286056 638125 735521 456429 3000000 2847000 6885146 5448347 146772 146772 2420493 2173626 2567265 2320398 9452411 7768745 0.01 0.01 500000000 500000000 49956505 49956505 37759911 37759911 499568 377596 440110645 229665735 -52607690 -55107131 38214 3470 388040737 174939670 397493148 182708414 16722467 2123970 24818304 4166270 10920334 1329291 16362063 2874784 5802134 794679 8456241 1291486 1540919 404277 3367620 706879 430759 62731 644101 70633 790012 302358 1370051 509975 10799261 7195193 18027462 10421097 75324 20593 140137 41186 13636276 7985152 23549371 11749770 -7834143 -7190473 -15093130 -10458284 1820162 225734 2612240 227266 -3883535 0 5608541 0 2267931 0 9532673 0 153000 -0 153000 -0 -687 0 -7235 0 281 -0 648 -0 50590 225734 17592571 227266 -7783553 -6964739 2499441 -10231018 -7783553 -6964739 2499441 -10231018 15314 0 34744 0 -7768239 -6964739 2534185 -10231018 -0.16 -0.32 0.06 -0.54 -0.16 -0.32 0.06 -0.54 48611102 21771954 44125630 18853428 48611102 21771954 44775513 18853428 15122018 151221 50580235 -35913514 0 14817942 483546 4835 -4835 1224606 12246 2424720 2436966 1883433 1883433 22940 22940 -3266279 -3266279 16830170 168302 54906493 -39179793 0 15895002 208336 2082 -2082 94650 947 366923 367870 4630 46 -46 150000 1500 -1500 8000000 80000 36416000 36496000 576831 576831 4936497 4936497 -6964739 -6964739 25287786 252877 97199116 -46144532 0 51307461 37759911 377596 229665734 -55107131 3470 174939670 745883 7460 -7460 74600 747 259587 260334 40000 400 -400 8823529 88235 138711758 138799993 350000 3500 3391500 3395000 291412 291412 3648567 3648567 10282994 10282994 19431 19431 47793923 477938 375960697 -44824137 22901 331637400 8352 83 -83 46230 467 326784 327251 108000 1080 -1080 2000000 20000 58178764 58198764 2178041 2178041 3467522 3467522 -7783554 -7783553 15314 15314 49956505 499568 440110645 -52607690 38214 388040737 2499441 -10231018 140137 41186 9585542 7419701 5608541 -0 9532673 -0 0 12146 -490971 0 8831972 118959 16597684 273614 10795249 409864 943639 151547 1356776 -60038 525959 -32660 153000 0 -352069 -57682 -38891945 -3862349 52500000 -0 20082674 0 508336 262751 2861101 -35786762 -262751 149999993 40000000 60000000 0 587584 367870 3395000 2436966 13001236 3504000 200981341 39300836 126302635 35175736 34744 0 103261397 3757323 229598776 38933059 <p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zMqS0F1NGTOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 1 – <span id="xdx_825_zNW8FoG53YJ3">Organization and nature of business</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unusual Machines, Inc. (“the Company”) is a Nevada corporation engaged in the commercial drone industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company acquired Rotor Lab Pty. Ltd., an Australian company (“Rotor Lab). See Note 3 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zXhfi3TdHpX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 2 – <span id="xdx_82E_zKsjNiOPwVH3">Summary of significant accounting policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX3ZaTpY7BKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zwCeIRHh9rj">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 12, 2026. The results for any interim period are not necessarily indicative of results for any future period. Prior-year and current-year year-to-date amounts have been conformed to the current presentation where applicable. These reclassifications affect only the presentation of operating expenses among departments and had no impact on total operating expenses, operating loss, net loss, earnings (loss) per share, total assets, liabilities, stockholders' equity, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zuePGe727RB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_zwKDy8oYRYKk">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include accounts of the Company and its wholly owned subsidiaries including UMAC IP Holdings Corp., Unusual Machines of Florida, Inc, Fat Shark, Rotor Riot and Rotor Lab since acquired on September 3, 2025. Intercompany transactions and balances have been eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--UseOfEstimates_z7UQwFEqaTMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zuhjedjZxRa9">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. Significant estimates reflected in these consolidated condensed financial statements include those used to (i) determine stock-based compensation, (ii) the fair value of assets acquired and liabilities assumed in business combinations, the fair value of shares issued as consideration and the fair value of contingent consideration in business combinations, (iii) reserves and allowances related to accounts receivable, and inventory, (iv) the evaluation of long-lived assets, including intangibles and goodwill, for impairment, (v) the fair value of lease liabilities and related right of use assets, (vi) the fair value of short-term investments including the value of unexercised warrants received, (vi) the warranty liability and sales returns reserves, and (vii) the deferred tax asset valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zkAARhzisfI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_z6kqQqf3a982">Cash and Cash Equivalents</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash deposits in multiple commercial banks and financial services companies. These financial institutions are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. At June 30, 2026 and December 31, 2025, the Company had approximately $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20260630_z1usKpuiP6Wi" title="Cash uninsured amount">229.1</span> million and $<span id="xdx_901_eus-gaap--CashUninsuredAmount_iI_pn6n6_c20251231_zSItt0mzooEj" title="Cash uninsured amount">103</span>.0 million, respectively, in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zXljrcpKeuQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zJLVjEvPPOV9">Accounts Receivable, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company carries its accounts receivable at invoiced amounts. The Company follows ASC 326, Financial Instruments – Credit Losses and has early adopted in fiscal year 2025, ASU 2025-05, under which the Company evaluates all credit losses as of the reporting date. On a periodic basis, the Company evaluates its accounts receivable and establishes an allowance for credit losses based on a history of past write-offs and collections and current credit conditions. Accounts are written-off as uncollectible at the discretion of management. At June 30, 2026 and December 31, 2025, the Company considers accounts receivable to be fully collectible; accordingly, <span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20260101__20260630_zmpjTxFcEII1" title="Credit losses"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20251231_zTtxyv3rNsw" title="Allowance for credit losses">no</span></span> allowance for credit losses has been established.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--EquityMethodInvestmentsPolicy_zq9Pm91uIBBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_znyT2fEN6kEe">Short-Term Equity Investments at Fair Value</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures its investments in equity securities, consisting of common stock, preferred stock, and non-public warrants at fair value with unrealized changes in value recognized in net income (loss) per ASC 321. The Company holds less than a 5% equity interest in each of the companies it invested in as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_ecustom--ShortTermEquityInvestmentsAtCostPolicyPolicyTextBlock_zWBzDLjymdyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_864_zqfyXbY50qa">Short-Term Equity Investments at Cost</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures its investment in privately held companies without readily determinable fair values using the Measurement Alternative per ASC 321. Investments are recorded at cost and subsequently adjusted only when there is an observable transaction or impairment under the Measurement Alternative.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zx9utE6jSPD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_866_zYtO4v98ScWg">Inventory</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of finished goods and raw materials, are stated at the lower of cost or net realizable value, and are measured using the first-in, first-out method. Cost components include direct materials, direct labor, an allocation of rent expense and depreciation for manufactured products, as well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various reference measures including current product selling prices, as well as evaluating for excess quantities and obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7esGyoUY8Ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zDFrPwIwQsdl">Property and equipment, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives which includes computer and office equipment of three to five years, motor production equipment of ten to fifteen years and tenant improvements of five to fifteen years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zj29SMKlRC3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_zjVCHwra0RG9">Leases</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies Accounting Standards Codification (ASC) 842, “Leases” which requires the recognition of assets and liabilities associated with lease agreements. The Company recognized a lease liability obligation and a right-of-use asset for the facilities leases in Orlando, FL and for the Canberra Australia lease related to the Rotor Lab acquisition as discussed in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide an implicit rate. Therefore, the Company used an effective discount rate of 8.24% based on its last debt financings. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets. Lease terms do not include an option to renew.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zY8a0annbsjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zagmvdLTuer3">Business Combinations</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for business combinations under ASC 805 using the acquisition method of accounting where the assets acquired and liabilities assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities is subjective in nature and often involves the use of significant estimates and assumptions used in valuations and estimates determined by management. Business acquisitions are included in the Company’s consolidated financial statements as of the date of the acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zuxciRlnSwg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zwlkG5UvVcDh">Goodwill and Long-lived Assets</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the future economic benefit arising from other assets acquired in an acquisition that are not individually identified and separately recognized. The Company tests goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however, the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. <span id="xdx_907_eus-gaap--GoodwillAndIntangibleAssetImpairment_do_c20260101__20260630_zr98iFZXfRT2" title="Impairment loss"><span id="xdx_900_eus-gaap--GoodwillAndIntangibleAssetImpairment_do_c20250101__20250630_zen6NSHrHFS6" title="Iimpairment loss on goodwill">No</span></span> impairment loss on goodwill was recognized during the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of fair value of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach, we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross margin, operating expenses, and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated weighted average cost of capital (i.e., the selected discount rate). Management’s assumptions are based on historical data, supplemented by current and anticipated market conditions, estimated growth rates, and management’s plans. Under the market approach, fair value is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of products and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews long-lived assets, including tangible assets and other intangible assets with definitive lives, for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-35, “Impairment or Disposal of Long-Lived Assets”. ASC 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. Amortizable intangible assets are assessed for impairment upon triggering events that indicate that the carrying value of an asset may not be recovered. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the intangible assets. <span id="xdx_90B_eus-gaap--AssetImpairmentCharges_do_c20260101__20260630_zB9U5dgQBzt1"><span id="xdx_905_eus-gaap--AssetImpairmentCharges_do_c20250101__20250630_zsvnpYEqsQwi">No</span></span> impairment charges were recorded by the Company during the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has certain indefinite-lived trademark assets that are reviewed for impairment by first performing a qualitative analysis in accordance with ASC 350-30 to determine whether it is more likely than not that the fair value of the indefinite-lived asset is less than its carrying value. If based on this assessment, management determines that impairment is not more than likely, then no further quantitative testing is required. However, if performing a qualitative analysis determines that is more likely than not that the fair value is less than its carrying value, then a quantitative analysis is performed in accordance with ASC 350-30-35, which occurs annually in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets. The Company performed only a qualitative analysis for 2025. The Company did <span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20260101__20260630_zjUMGAN0tlk4"><span id="xdx_902_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20250101__20250630_zo6r8LvOKGcf">no</span></span>t record an impairment during the six months ended June 30, 2026 and 2025, respectively related to the indefinite-lived assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zkzbsYHNlHg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zQARU9omS4hi">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The guidance establishes three levels of the fair value hierarchy as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the fair value measurements of the Company’s financial assets and liabilities as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zdo1oVEwcXfh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z1sAC5rxuphl" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zuD7qrV8IPd9" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXJD0nXqPhjk" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8zqIvjjVKed" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBbxwojQE0D3" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z9ltGhroeYTb" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6mFwYt9ehJe" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOrEXFakYTE5" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdfTIIuz2EL6" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember_zHUGqTDYQGP7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT2nhI7qqOB6" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXKeQGJmONMb" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGyJIVuGshn2" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zn3jxELN2tUf" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">39,273,449</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zjDr7vzAkam7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">34,702,949</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znenZcW1U2F5" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,790,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUHecETKJxSl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zMKTsBgmY9c2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zW50S78zZf85" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGlDHIXbraij" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZoHVz0YjjF2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zdbfqLgc7uyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for common stock for short-term investments based on the quoted trading price as of the close of the market multiplied by the total shares held by the Company as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for pre-funded warrants for short-term investments based on the quoted trading price as of the close of the market multiplied by the total common equivalent shares held by the Company as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the non-public warrants investment in 2026 was determined using a Black-Scholes pricing model which values the warrants based on the stock price at the valuation date, the expected life of the warrant, the estimated volatility of the stock of the investee, and the risk-free interest rate over the expected life of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following inputs related to the non-public warrants fair value as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_zKBdWwVd47V3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zHt1Hz2dLhPj" style="display: none">Schedule of assumptions used</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental Information</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-public Warrants</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term of the warrants (years)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zNpBLfpuxPL7" title="Assumptions used">1.00</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_ze0xVjqjAnWh" title="Assumptions used">4.33</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant exercise price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputQuotedPriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zH6xL3eCkVA5" title="Assumptions used">6.00</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zTOigkW1Daj" title="Assumptions used">3.98%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zHOc3tlTgbCh" title="Assumptions used">116.38%</span></span></td> <td> </td></tr> </table> <p id="xdx_8A5_zIaPKEbu7cz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contingent consideration from the Rotor Lab acquisition was based on management’s estimate at the acquisition date of $<span id="xdx_90F_eus-gaap--AssetAcquisitionContingentConsiderationLiabilityNoncurrent_iI_pp0p0_c20251231_zEqqwRacs29j" title="Contingent consideration">2,847,000</span>, which is based on the fair value of contingent consideration determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the expected contingent consideration from the Rotor Lab acquisition to $<span id="xdx_90B_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20260630_zwgkXEQ2WNH6" title="Contingent consideration expected">3,000,000</span> as of June 30, 2026 based on actual sales during the period based on managements updated estimate. See Note 3 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in Level 3 financial instruments are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zqAWkTDPw1f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zp1QQOPQZyQ6" style="display: none">Schedule of level 3 financial instruments</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td> </td> <td colspan="3" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Change in</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Settlements</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: left">Non-public warrants investment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYmHNmA4SGd8" style="width: 11%; text-align: right" title="Assets, fair value">685,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlIdKjRo7xU" style="width: 11%; text-align: right" title="Purchases, issuances and settlements">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIVzVmYuMeoi" style="width: 11%; text-align: right" title="Change in fair value">95,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLNR3dt8XWRa" style="width: 11%; text-align: right" title="Assets, fair value">780,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration from Rotor Lab acquisition</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BFqExEMbL1" style="text-align: right" title="Assets, fair value">2,847,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9BqrWB0hGSe" style="text-align: right" title="Purchases, issuances and settlements">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgDRGovURacf" style="text-align: right" title="Change in fair value">153,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZSMG0uCteA8" style="text-align: right" title="Assets, fair value">3,000,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AD_zmWjpePMyqdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company's financial instruments mainly consist of cash, receivables, short-term investments, other current assets, accounts payable, and accrued expenses. The carrying amounts of cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Short Term Investments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our short-term investments consisting of investments accounted for at fair value and investments accounted for at cost were as follows as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zy36pislzpdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td id="xdx_8BF_zsSWsn93Dpak" style="display: none">Schedule of short-term investments</td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_z6JSoGWxkqSe" style="width: 11%; text-align: right" title="Investments owned at cost">28,150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zjTGm8UKwfc7" style="width: 11%; text-align: right" title="Cumulative unrealized gains (losses)">6,552,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zXTAHMSvmmG3" style="width: 11%; text-align: right" title="Investments owned at fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zzOxXXpAvES7" style="text-align: right" title="Investments owned at cost">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zi386OLBMsIh" style="text-align: right" title="Cumulative unrealized gains (losses)">940,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zcWkDwYgsFvh" style="text-align: right" title="Investments owned at fair value">3,790,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztOFZ1nc3efh" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zIbvrgGVfLcj" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">585,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zAOGy4Dnay25" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zH4nRIg9aXw3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">31,195,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zV9aEf2ZQLv4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">8,078,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zFD07vzE1wr7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">39,273,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Impairment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zlYipZQMOwpi" style="width: 11%; text-align: right">12,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z2oUeldpz9e" style="width: 11%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zibzlWCjbaEf" style="width: 11%; text-align: right" title="Investment owned at cost, adjusted">12,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zGsZPBAxxw38" style="text-align: right">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zgc9tsi291he" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zytfsy0klCs2" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zYUWHzA5r2xb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zdKLO6SJ69H9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_z7PzTZZWpx77" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zzeZkTpLoxv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--StandardProductWarrantyPolicy_zqxFrTunhbYk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zPTlRdML3uw2">Accrued Warranty</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fat Shark generally provides a one-year warranty on all of its products, except in certain European countries where it can be two years for some consumer-focused products from the date of shipment. If a defect arises during the warranty period, Fat Shark will either (i) repair the affected product at no charge using new parts or parts that are equivalent to new in performance and reliability; (ii) exchange the affected product with a functionally equivalent product; or (iii) refund the original purchase price for the affected product. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 24 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize the additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260630_zvUpDJuvAqL">16,207</span> and $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231_zn4Wb7ssDt6f" title="Accrued expenses">19,602</span> as of June 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rotor Riot does not provide any warranty of any kind for any of the equipment it sells or otherwise distributes. Consumers assume all risk for any products purchased or received from Rotor Riot.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rotor Lab does not provide any warranty, but does provide for a seven day defect period. Rotor Lab has not had any material defects for products sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective September 2025, Unusual Machines, the parent company which manufactures motors has a limited warranty in which it warrants to customers that their products will be free from defects in material and workmanship under normal use and service for up to 90 days. The limited warranty covers manufacturing defects and premature failures and extends only to the original customer and is non-transferrable. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260630__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zfq1e1Q5rau4" title="Accrued liabilities">317,009</span> as of June 30, 2026, and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zmCmUNWgbimj" title="Accrued liabilities">0</span> as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zWMmHUjYRq76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zqxOeUB0jELk">Revenue Recognition</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 1: Identify the contract with a customer;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 2: Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 3: Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 4: Allocate the transaction price to the performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 5: Recognize revenue when (or as) the Company satisfies a performance obligation at a point in time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company receives revenues from the sale of drone and drone parts to enterprise customers and distributors (“Enterprise Revenue”) and individual consumers (“Retail Revenue”). Revenue is recognized at a point in time when the products are shipped and the price is fixed or determinable, no other significant obligations of the Company exist and collectability is probable. Revenue is recognized when the title to the products has been passed to the customer, which is the date the products are shipped to the customer. This is the date the performance obligation has been met. The Company’s retail return policy allows for certain non-custom or built-to-order products to be returned up to 15 days after the original order is placed so long as it meets specific requirements as outlined in its return policy. The Company’s enterprise return policy allows for returns related to defective product so long as it meets the requirements in its policy. The historical sales returns for retail customers is de minimis and the Company does not have a specific sales return allowance for retail orders. The Company does not have any historical returns for enterprise orders and as such has not recorded a sales returns allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Disaggregation of Revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zIsUeOy71Yfd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span id="xdx_8B1_z8ToMQTW65Lj" style="display: none">Schedule of disaggregated by revenue</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><b>For the Six months Ended</b><br/> <b>June 30</b></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zKQvWbTzKQLf" style="width: 13%; text-align: right" title="Total revenue">3,174,925</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z3lmUIp8Iii3" style="width: 13%; text-align: right" title="Total revenue">2,891,263</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zpCjxq4dTdj" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">21,643,379</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zO85BaeIxDH8" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,275,007</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20260101__20260630_z1BprDcGjwr1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">24,818,304</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250101__20250630_z03kg9U4Mvoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,166,270</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>For the Three months Ended</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>June 30</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Retail revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zHWLPy7nEMr5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">2,392,095</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zecb8KsQBlB5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">1,292,963</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zOJIhJ1ZSW91" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">14,330,372</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zZ09fKlxvZe2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">831,007</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20260401__20260630_zW6XeqYcu2r2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">16,722,467</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20250401__20250630_zsagSjVQITOi" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">2,123,970</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zXAjpyfMWL96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had revenue outside the United States of approximately $<span id="xdx_90B_eus-gaap--Revenues_pn5n6_c20260101__20260630__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zbffKz0nYVgh" title="Foreign sales revenue">1.4</span> million and $<span id="xdx_909_eus-gaap--Revenues_pn5n6_c20250101__20250630__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zSwfE6Xrmay9" title="Foreign sales revenue">0.2</span> million for the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_ecustom--RevenueRecognitionDeferredRevenue1_z4OWFSDlvP5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zyhShGOjQ677">Deferred Revenue</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relates to orders placed and payment received, but not yet fulfilled. All deferred revenue is expected to be recognized within one year. Deferred revenue related to orders placed, but not yet fulfilled totaled $<span id="xdx_905_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20260630_zldJguGKyGWi" title="Deferred revenue, current">286,056</span> and $<span id="xdx_908_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20251231_zR92UiokWJ5j" title="Deferred revenue, current">638,125</span> as of June 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_zO5osorRmYph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zokpXXw3ZpPc">Cost of Goods Sold</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of goods sold includes inventory costs which includes an allocation for labor and rent for our manufactured products, direct packaging costs and production related depreciation, if any. Depreciation included in cost of goods sold for the six months ended June 30, 2026 and 2025 was $<span id="xdx_90F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20260101__20260630_zz9L7TsKegt9" title="Cost of goods sold">74,133</span> and $<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20250101__20250630_z7PRdDtJHaXd" title="Cost of goods sold">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zne8ggsNXnUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zl2MCJ220fHl">Shipping and Handling Costs</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs incurred for products shipped to customers are included in operations expenses and amounted to $<span id="xdx_902_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260630__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zlkZTwCqWOFe" title="Shipping and handling costs">722,116</span> and $<span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250630__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zrQGRsjAZgXg" title="Shipping and handling costs">147,572</span> for the six months ended June 30, 2026 and 2025, respectively. Shipping and handling costs charged to customers are included in sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_ztqywns3FXVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zwC68emf8gQb">Research and Development</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development costs, materials, and are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zDayMU5twAm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zPh97nV0LAkl">Income Taxes</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realizable in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zP2uJqjMp16g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zIBpFFQ1gioj">Stock-Based Compensation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation – Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility based on comparative companies through December 31, 2025, and historical volatility beginning of January 1, 2026, expected term using the simplified method and future dividends. The Company recognizes forfeitures as they occur. The fair value of stock grants is based on our stock price on the date of grant. Compensation costs are recognized on a straight-line basis over the requisite service period which is the vesting term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_ecustom--WarrantsPolicyTextBlock_zvmfmWmX8f8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zicUfyC8RCX7">Warrants</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants to purchase shares of its common stock in accordance with the guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). The Company classifies warrants issued for the purchase of shares of its common stock as either equity or liability instruments based on an assessment of the specific terms and conditions of each respective contract. The assessment considers whether the warrants are freestanding financial instruments or embedded in a host instrument, whether the warrants meet the definition of a liability pursuant to ASC 480, whether the warrants meet the definition of a derivative under ASC 815, and whether the warrants meet all of the requirements for equity classification under ASC 815. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants classified as liabilities are recognized as a non-cash gain or loss in the consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbLKARRCECHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zdsoMpTMgvh2">Foreign Currency</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s wholly owned subsidiary’s functional currency is the Australia dollar (AUD). For financial reporting purposes, the Australia dollar has been translated into the Company’s reporting currency, which is the United States dollar (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenue and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statement of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Transaction gains and losses from transactions denominated in a foreign currency are recognized in other income (expense) in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the cumulative translation adjustments were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_ztNSu2gHrDNk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zeT92sLwqZyj" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_d0_c20260101__20260630_zrxglxgFYAfc" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20260101__20260630_zpPDIjyEGqOa" title="Foreign currency translation adjustment related to Rotor Lab">34,744</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260630_z5zx1pZDwl4j" title="Ending balance">38,214</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z651RQZvUA15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zuySqQ8EOr4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_z3jc7JKcm9Gl">Net Loss per Share</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per share is calculated based on the weighted-average of common shares outstanding in accordance with FASB ASC Topic 260, <i>Earnings per Share</i>. Diluted net loss per share is calculated based on the weighted-average number of common shares outstanding plus the effect of dilutive potential common shares. When the Company reports a net loss, the calculation of diluted net loss per share excludes potential common shares as the effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic and diluted net income (loss) per common share:</p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJWHDusa9cTc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%"><span id="xdx_8BC_z9rux6wIhe79"><b style="display: none">Schedule of income (loss) per share</b></span></td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_49C_20260101__20260630_z2i7KCpg2UOe" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_491_20250101__20250630_zlc5wib4u3rl" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">For the Six months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Net (loss) income per common share – basic:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_ziDBtNurpvn1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Net (loss) income</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">2,499,441</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(10,231,018</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zOC7car8dkI4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Less: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zsPzJWffxAK6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net (loss) income allocated to common stockholders</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zoYb0Am12S5g" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - basic</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,125,630</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareBasic_zzq9AKqYboM3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - basic</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Net (loss) income per common share – diluted:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zq53zAMheUPg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net (loss) income</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,499,441</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(10,231,018</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zaBBO93jLsif" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Add: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_zPpwkg4aYFd6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Numerator for net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zBzyw4iI4yGi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Weighted average common shares outstanding - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_zL2O6P1rSa2a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income per share of common stock attributable to common stockholders.</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zBupT1norJw2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Reconciliation of basic to diluted weighted average shares)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B2_zjwjthWPiXD6" style="display: none">Schedule of reconciliation of basic to diluted weighted average shares</span> </td><td> </td> <td colspan="3" id="xdx_496_20260101__20260630_ztQbwJq1dV6e" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_492_20250101__20250630_zwg4UgAdWFRi" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Six months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zz4CmDYgD1Ae" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Weighted average shares used in computing net income per share of common stock, basic</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">44,125,630</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">18,853,428</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Add incremental shares:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_zFLgN75i0tUf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Unvested restricted stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zVLgCXnr1Xej" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Stock based awards (options)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">394,889</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zhWhzXdnOLta" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average shares used in computing net income per share of common stock, diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zCgJpa5C58Mk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the potentially dilutive shares that were excluded for the three months ended June 30, 2026, from the computation of diluted net loss per share of common stock attributable to common stockholders, because their effect was anti-dilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zwbcmX4v8j8a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - schedule of antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8BA_zVilvH5YrP9b"><b style="display: none">Schedule of antidilutive shares</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2026</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Unvested stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_zfFXAdv46NPj" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">808,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_z50kJG1jsnki" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">330,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Unvested restricted stock awards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zO2fYgFkNus1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">914,792</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zpcLo9rhjVal" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Representative warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zfrKPadCD8vb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zocsy8qZlSS6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">PIPE warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_zXpBX4RNGZDk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_z3u5yiqPf5Q3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">164,473</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630_zg3HA7ob58I1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">1,723,646</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630_zYz4EUT94pZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">702,973</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z0NS1h9DXkvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zG9FChZHh9Rh">Segment Reporting</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Unusual Machines, which sells drones and drone-related components, operates as a <span id="xdx_907_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260630_zMHBWfMolUc2" title="Reportable segment::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl1041">single</span></span> reportable segment entity. Our chief operating decision maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Chief Executive Officer is regularly provided with consolidated revenue and expenses consistent with those presented in the consolidated statements of operations and assets and liabilities consistent with those presented in the consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zfF0W5MVUB36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zTxr29iYb4L2">Recent Accounting Pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued ASU No. 2024-03, “Disaggregation of Income Statement Expenses” which requires disaggregated disclosure of income statement expenses into specified categories in disclosures within the footnotes to the financial statements. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, the FASB issued ASU No. 2025-4, “Compensation – Stock Compensation and Revenue From Contracts With Customers” which provides clarifications to share-based consideration payable to a customer. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zX3ZaTpY7BKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zwCeIRHh9rj">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 12, 2026. The results for any interim period are not necessarily indicative of results for any future period. Prior-year and current-year year-to-date amounts have been conformed to the current presentation where applicable. These reclassifications affect only the presentation of operating expenses among departments and had no impact on total operating expenses, operating loss, net loss, earnings (loss) per share, total assets, liabilities, stockholders' equity, or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zuePGe727RB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_zwKDy8oYRYKk">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include accounts of the Company and its wholly owned subsidiaries including UMAC IP Holdings Corp., Unusual Machines of Florida, Inc, Fat Shark, Rotor Riot and Rotor Lab since acquired on September 3, 2025. Intercompany transactions and balances have been eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--UseOfEstimates_z7UQwFEqaTMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_zuhjedjZxRa9">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. Significant estimates reflected in these consolidated condensed financial statements include those used to (i) determine stock-based compensation, (ii) the fair value of assets acquired and liabilities assumed in business combinations, the fair value of shares issued as consideration and the fair value of contingent consideration in business combinations, (iii) reserves and allowances related to accounts receivable, and inventory, (iv) the evaluation of long-lived assets, including intangibles and goodwill, for impairment, (v) the fair value of lease liabilities and related right of use assets, (vi) the fair value of short-term investments including the value of unexercised warrants received, (vi) the warranty liability and sales returns reserves, and (vii) the deferred tax asset valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zkAARhzisfI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_z6kqQqf3a982">Cash and Cash Equivalents</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid debt instruments and other short-term investments with maturities of three months or less, when purchased, to be cash equivalents. The Company maintains cash deposits in multiple commercial banks and financial services companies. These financial institutions are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. At June 30, 2026 and December 31, 2025, the Company had approximately $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20260630_z1usKpuiP6Wi" title="Cash uninsured amount">229.1</span> million and $<span id="xdx_901_eus-gaap--CashUninsuredAmount_iI_pn6n6_c20251231_zSItt0mzooEj" title="Cash uninsured amount">103</span>.0 million, respectively, in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of the financial institutions with which it invests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 229100000 103000000 <p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zXljrcpKeuQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zJLVjEvPPOV9">Accounts Receivable, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company carries its accounts receivable at invoiced amounts. The Company follows ASC 326, Financial Instruments – Credit Losses and has early adopted in fiscal year 2025, ASU 2025-05, under which the Company evaluates all credit losses as of the reporting date. On a periodic basis, the Company evaluates its accounts receivable and establishes an allowance for credit losses based on a history of past write-offs and collections and current credit conditions. Accounts are written-off as uncollectible at the discretion of management. At June 30, 2026 and December 31, 2025, the Company considers accounts receivable to be fully collectible; accordingly, <span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20260101__20260630_zmpjTxFcEII1" title="Credit losses"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_do_c20250101__20251231_zTtxyv3rNsw" title="Allowance for credit losses">no</span></span> allowance for credit losses has been established.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 <p id="xdx_84E_eus-gaap--EquityMethodInvestmentsPolicy_zq9Pm91uIBBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_znyT2fEN6kEe">Short-Term Equity Investments at Fair Value</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures its investments in equity securities, consisting of common stock, preferred stock, and non-public warrants at fair value with unrealized changes in value recognized in net income (loss) per ASC 321. The Company holds less than a 5% equity interest in each of the companies it invested in as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_ecustom--ShortTermEquityInvestmentsAtCostPolicyPolicyTextBlock_zWBzDLjymdyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_864_zqfyXbY50qa">Short-Term Equity Investments at Cost</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures its investment in privately held companies without readily determinable fair values using the Measurement Alternative per ASC 321. Investments are recorded at cost and subsequently adjusted only when there is an observable transaction or impairment under the Measurement Alternative.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--InventoryPolicyTextBlock_zx9utE6jSPD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_866_zYtO4v98ScWg">Inventory</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of finished goods and raw materials, are stated at the lower of cost or net realizable value, and are measured using the first-in, first-out method. Cost components include direct materials, direct labor, an allocation of rent expense and depreciation for manufactured products, as well as in-bound freight. At each balance sheet date, the Company evaluates the net realizable value of its inventory using various reference measures including current product selling prices, as well as evaluating for excess quantities and obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7esGyoUY8Ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zDFrPwIwQsdl">Property and equipment, net</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives which includes computer and office equipment of three to five years, motor production equipment of ten to fifteen years and tenant improvements of five to fifteen years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p id="xdx_848_eus-gaap--LesseeLeasesPolicyTextBlock_zj29SMKlRC3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_zjVCHwra0RG9">Leases</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies Accounting Standards Codification (ASC) 842, “Leases” which requires the recognition of assets and liabilities associated with lease agreements. The Company recognized a lease liability obligation and a right-of-use asset for the facilities leases in Orlando, FL and for the Canberra Australia lease related to the Rotor Lab acquisition as discussed in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines if a contract is a lease or contains a lease at inception. Operating lease liabilities are measured, on each reporting date, based on the present value of the future minimum lease payments over the remaining lease term. The Company's leases do not provide an implicit rate. Therefore, the Company used an effective discount rate of 8.24% based on its last debt financings. Operating lease assets are measured by adjusting the lease liability for lease incentives, initial direct costs incurred and asset impairments. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term with the operating lease asset reduced by the amount of the expense. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets. Lease terms do not include an option to renew.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zY8a0annbsjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zagmvdLTuer3">Business Combinations</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for business combinations under ASC 805 using the acquisition method of accounting where the assets acquired and liabilities assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities is subjective in nature and often involves the use of significant estimates and assumptions used in valuations and estimates determined by management. Business acquisitions are included in the Company’s consolidated financial statements as of the date of the acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zuxciRlnSwg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zwlkG5UvVcDh">Goodwill and Long-lived Assets</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the future economic benefit arising from other assets acquired in an acquisition that are not individually identified and separately recognized. The Company tests goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however, the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. <span id="xdx_907_eus-gaap--GoodwillAndIntangibleAssetImpairment_do_c20260101__20260630_zr98iFZXfRT2" title="Impairment loss"><span id="xdx_900_eus-gaap--GoodwillAndIntangibleAssetImpairment_do_c20250101__20250630_zen6NSHrHFS6" title="Iimpairment loss on goodwill">No</span></span> impairment loss on goodwill was recognized during the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of fair value of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach, we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross margin, operating expenses, and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated weighted average cost of capital (i.e., the selected discount rate). Management’s assumptions are based on historical data, supplemented by current and anticipated market conditions, estimated growth rates, and management’s plans. Under the market approach, fair value is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of products and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews long-lived assets, including tangible assets and other intangible assets with definitive lives, for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-35, “Impairment or Disposal of Long-Lived Assets”. ASC 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. Amortizable intangible assets are assessed for impairment upon triggering events that indicate that the carrying value of an asset may not be recovered. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the intangible assets. <span id="xdx_90B_eus-gaap--AssetImpairmentCharges_do_c20260101__20260630_zB9U5dgQBzt1"><span id="xdx_905_eus-gaap--AssetImpairmentCharges_do_c20250101__20250630_zsvnpYEqsQwi">No</span></span> impairment charges were recorded by the Company during the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has certain indefinite-lived trademark assets that are reviewed for impairment by first performing a qualitative analysis in accordance with ASC 350-30 to determine whether it is more likely than not that the fair value of the indefinite-lived asset is less than its carrying value. If based on this assessment, management determines that impairment is not more than likely, then no further quantitative testing is required. However, if performing a qualitative analysis determines that is more likely than not that the fair value is less than its carrying value, then a quantitative analysis is performed in accordance with ASC 350-30-35, which occurs annually in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets. The Company performed only a qualitative analysis for 2025. The Company did <span id="xdx_909_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20260101__20260630_zjUMGAN0tlk4"><span id="xdx_902_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20250101__20250630_zo6r8LvOKGcf">no</span></span>t record an impairment during the six months ended June 30, 2026 and 2025, respectively related to the indefinite-lived assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 0 0 0 0 <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zkzbsYHNlHg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zQARU9omS4hi">Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The guidance establishes three levels of the fair value hierarchy as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 1</i>: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 2</i>: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Level 3</i>: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table details the fair value measurements of the Company’s financial assets and liabilities as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zdo1oVEwcXfh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z1sAC5rxuphl" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zuD7qrV8IPd9" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXJD0nXqPhjk" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8zqIvjjVKed" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBbxwojQE0D3" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z9ltGhroeYTb" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6mFwYt9ehJe" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOrEXFakYTE5" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdfTIIuz2EL6" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember_zHUGqTDYQGP7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT2nhI7qqOB6" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXKeQGJmONMb" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGyJIVuGshn2" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zn3jxELN2tUf" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">39,273,449</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zjDr7vzAkam7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">34,702,949</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znenZcW1U2F5" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,790,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUHecETKJxSl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zMKTsBgmY9c2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zW50S78zZf85" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGlDHIXbraij" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZoHVz0YjjF2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zdbfqLgc7uyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for common stock for short-term investments based on the quoted trading price as of the close of the market multiplied by the total shares held by the Company as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculated the fair value for pre-funded warrants for short-term investments based on the quoted trading price as of the close of the market multiplied by the total common equivalent shares held by the Company as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the non-public warrants investment in 2026 was determined using a Black-Scholes pricing model which values the warrants based on the stock price at the valuation date, the expected life of the warrant, the estimated volatility of the stock of the investee, and the risk-free interest rate over the expected life of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following inputs related to the non-public warrants fair value as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_zKBdWwVd47V3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zHt1Hz2dLhPj" style="display: none">Schedule of assumptions used</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental Information</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-public Warrants</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term of the warrants (years)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zNpBLfpuxPL7" title="Assumptions used">1.00</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_ze0xVjqjAnWh" title="Assumptions used">4.33</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant exercise price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputQuotedPriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zH6xL3eCkVA5" title="Assumptions used">6.00</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zTOigkW1Daj" title="Assumptions used">3.98%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zHOc3tlTgbCh" title="Assumptions used">116.38%</span></span></td> <td> </td></tr> </table> <p id="xdx_8A5_zIaPKEbu7cz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contingent consideration from the Rotor Lab acquisition was based on management’s estimate at the acquisition date of $<span id="xdx_90F_eus-gaap--AssetAcquisitionContingentConsiderationLiabilityNoncurrent_iI_pp0p0_c20251231_zEqqwRacs29j" title="Contingent consideration">2,847,000</span>, which is based on the fair value of contingent consideration determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the expected contingent consideration from the Rotor Lab acquisition to $<span id="xdx_90B_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20260630_zwgkXEQ2WNH6" title="Contingent consideration expected">3,000,000</span> as of June 30, 2026 based on actual sales during the period based on managements updated estimate. See Note 3 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in Level 3 financial instruments are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zqAWkTDPw1f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zp1QQOPQZyQ6" style="display: none">Schedule of level 3 financial instruments</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td> </td> <td colspan="3" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Change in</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Settlements</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: left">Non-public warrants investment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYmHNmA4SGd8" style="width: 11%; text-align: right" title="Assets, fair value">685,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlIdKjRo7xU" style="width: 11%; text-align: right" title="Purchases, issuances and settlements">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIVzVmYuMeoi" style="width: 11%; text-align: right" title="Change in fair value">95,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLNR3dt8XWRa" style="width: 11%; text-align: right" title="Assets, fair value">780,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration from Rotor Lab acquisition</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BFqExEMbL1" style="text-align: right" title="Assets, fair value">2,847,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9BqrWB0hGSe" style="text-align: right" title="Purchases, issuances and settlements">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgDRGovURacf" style="text-align: right" title="Change in fair value">153,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZSMG0uCteA8" style="text-align: right" title="Assets, fair value">3,000,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AD_zmWjpePMyqdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company's financial instruments mainly consist of cash, receivables, short-term investments, other current assets, accounts payable, and accrued expenses. The carrying amounts of cash, receivables, other current assets, accounts payable, and accrued expenses approximate fair value due to the short-term nature of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Short Term Investments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our short-term investments consisting of investments accounted for at fair value and investments accounted for at cost were as follows as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zy36pislzpdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td id="xdx_8BF_zsSWsn93Dpak" style="display: none">Schedule of short-term investments</td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_z6JSoGWxkqSe" style="width: 11%; text-align: right" title="Investments owned at cost">28,150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zjTGm8UKwfc7" style="width: 11%; text-align: right" title="Cumulative unrealized gains (losses)">6,552,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zXTAHMSvmmG3" style="width: 11%; text-align: right" title="Investments owned at fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zzOxXXpAvES7" style="text-align: right" title="Investments owned at cost">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zi386OLBMsIh" style="text-align: right" title="Cumulative unrealized gains (losses)">940,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zcWkDwYgsFvh" style="text-align: right" title="Investments owned at fair value">3,790,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztOFZ1nc3efh" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zIbvrgGVfLcj" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">585,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zAOGy4Dnay25" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zH4nRIg9aXw3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">31,195,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zV9aEf2ZQLv4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">8,078,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zFD07vzE1wr7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">39,273,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Impairment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zlYipZQMOwpi" style="width: 11%; text-align: right">12,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z2oUeldpz9e" style="width: 11%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zibzlWCjbaEf" style="width: 11%; text-align: right" title="Investment owned at cost, adjusted">12,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zGsZPBAxxw38" style="text-align: right">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zgc9tsi291he" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zytfsy0klCs2" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zYUWHzA5r2xb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zdKLO6SJ69H9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_z7PzTZZWpx77" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zzeZkTpLoxv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zdo1oVEwcXfh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - financial assets and liabilities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z1sAC5rxuphl" style="display: none">Schedule of financial assets and liabilities</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Short term investments – assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 40%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zuD7qrV8IPd9" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXJD0nXqPhjk" style="width: 11%; text-align: right" title="Assets, fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8zqIvjjVKed" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBbxwojQE0D3" style="width: 11%; text-align: right" title="Assets, fair value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember_z9ltGhroeYTb" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6mFwYt9ehJe" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOrEXFakYTE5" style="text-align: right" title="Assets, fair value">3,790,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--PreFundedWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdfTIIuz2EL6" style="text-align: right" title="Assets, fair value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember_zHUGqTDYQGP7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT2nhI7qqOB6" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXKeQGJmONMb" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGyJIVuGshn2" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total short-term investments – assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember_zn3jxELN2tUf" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">39,273,449</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zjDr7vzAkam7" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">34,702,949</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znenZcW1U2F5" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">3,790,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--TotalShortTermInvestmentsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUHecETKJxSl" style="border-bottom: Black 1pt solid; text-align: right" title="Assets, fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Contingent consideration from Rotor Lab acquisition</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember_zMKTsBgmY9c2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zW50S78zZf85" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGlDHIXbraij" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZoHVz0YjjF2" style="border-bottom: Black 2.5pt double; text-align: right" title="Assets, fair value">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 34702949 34702949 0 0 3790500 0 3790500 0 780000 0 0 780000 39273449 34702949 3790500 780000 3000000 0 0 3000000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_zKBdWwVd47V3" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zHt1Hz2dLhPj" style="display: none">Schedule of assumptions used</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supplemental Information</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-public Warrants</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term of the warrants (years)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zNpBLfpuxPL7" title="Assumptions used">1.00</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_ze0xVjqjAnWh" title="Assumptions used">4.33</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant exercise price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputQuotedPriceMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zH6xL3eCkVA5" title="Assumptions used">6.00</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zTOigkW1Daj" title="Assumptions used">3.98%</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20260101__20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonPublicWarrantsMember_zHOc3tlTgbCh" title="Assumptions used">116.38%</span></span></td> <td> </td></tr> </table> 1.00 4.33 6.00 3.98% 116.38% 2847000 3000000 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zqAWkTDPw1f1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Changes in Level 3 financial instruments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_zp1QQOPQZyQ6" style="display: none">Schedule of level 3 financial instruments</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td> </td> <td colspan="3" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Purchases,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Issuances and</b></p></td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Change in</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">June 30,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Settlements</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: left">Non-public warrants investment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYmHNmA4SGd8" style="width: 11%; text-align: right" title="Assets, fair value">685,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlIdKjRo7xU" style="width: 11%; text-align: right" title="Purchases, issuances and settlements">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIVzVmYuMeoi" style="width: 11%; text-align: right" title="Change in fair value">95,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--WarrantsInvestmentMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLNR3dt8XWRa" style="width: 11%; text-align: right" title="Assets, fair value">780,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Contingent consideration from Rotor Lab acquisition</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20251231__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BFqExEMbL1" style="text-align: right" title="Assets, fair value">2,847,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9BqrWB0hGSe" style="text-align: right" title="Purchases, issuances and settlements">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgDRGovURacf" style="text-align: right" title="Change in fair value">153,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iI_d0_c20260630__us-gaap--FinancialInstrumentAxis__custom--RotorLabContingentConsiderationMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZSMG0uCteA8" style="text-align: right" title="Assets, fair value">3,000,000</td><td style="text-align: left"> </td></tr> </table> 685000 0 95000 780000 2847000 0 153000 3000000 <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_zy36pislzpdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Fair value of investments)"> <tr style="vertical-align: bottom"> <td id="xdx_8BF_zsSWsn93Dpak" style="display: none">Schedule of short-term investments</td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at fair value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cumulative Unrealized Gains (Losses)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_z6JSoGWxkqSe" style="width: 11%; text-align: right" title="Investments owned at cost">28,150,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zjTGm8UKwfc7" style="width: 11%; text-align: right" title="Cumulative unrealized gains (losses)">6,552,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicCommonStockMember_zXTAHMSvmmG3" style="width: 11%; text-align: right" title="Investments owned at fair value">34,702,949</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Pre-funded warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zzOxXXpAvES7" style="text-align: right" title="Investments owned at cost">2,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zi386OLBMsIh" style="text-align: right" title="Cumulative unrealized gains (losses)">940,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PublicPreFundedWarrantsMember_zcWkDwYgsFvh" style="text-align: right" title="Investments owned at fair value">3,790,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-public warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_ztOFZ1nc3efh" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at cost">195,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zIbvrgGVfLcj" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative unrealized gains (losses)">585,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--NonPublicWarrantsMember_zAOGy4Dnay25" style="border-bottom: Black 1pt solid; text-align: right" title="Investments owned at fair value">780,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtCost_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zH4nRIg9aXw3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at cost">31,195,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtAndEquitySecuritiesUnrealizedGainLoss_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zV9aEf2ZQLv4" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Cumulative unrealized gains (losses)">8,078,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--PubliclyHeldInvestmentsMember_zFD07vzE1wr7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investments owned at fair value">39,273,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold">Short-term investments at cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Impairment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted Cost</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zlYipZQMOwpi" style="width: 11%; text-align: right">12,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_z2oUeldpz9e" style="width: 11%; text-align: right" title="Impairment charges">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--CommonStockMember_zibzlWCjbaEf" style="width: 11%; text-align: right" title="Investment owned at cost, adjusted">12,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zGsZPBAxxw38" style="text-align: right">5,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zgc9tsi291he" style="text-align: right" title="Impairment charges">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__us-gaap--PreferredStockMember_zytfsy0klCs2" style="text-align: right" title="Investment owned at cost, adjusted">5,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Pre-funded warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right" title="Investment owned at cost, adjusted">30,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zYUWHzA5r2xb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetImpairmentCharges_d0_c20260101__20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_zdKLO6SJ69H9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Impairment charges">–</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_ecustom--AdjustedInvestmentOwnedAtCost_iI_c20260630__us-gaap--FinancialInstrumentAxis__custom--CommonAndPreferredStockMember_z7PzTZZWpx77" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Investment owned at cost, adjusted">47,500,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 28150000 6552949 34702949 2850000 940500 3790500 195000 585000 780000 31195000 8078449 39273449 12500000 0 12500000 5000000 0 5000000 47500000 0 47500000 <p id="xdx_84C_eus-gaap--StandardProductWarrantyPolicy_zqxFrTunhbYk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zPTlRdML3uw2">Accrued Warranty</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fat Shark generally provides a one-year warranty on all of its products, except in certain European countries where it can be two years for some consumer-focused products from the date of shipment. If a defect arises during the warranty period, Fat Shark will either (i) repair the affected product at no charge using new parts or parts that are equivalent to new in performance and reliability; (ii) exchange the affected product with a functionally equivalent product; or (iii) refund the original purchase price for the affected product. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 24 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize the additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_904_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260630_zvUpDJuvAqL">16,207</span> and $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231_zn4Wb7ssDt6f" title="Accrued expenses">19,602</span> as of June 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rotor Riot does not provide any warranty of any kind for any of the equipment it sells or otherwise distributes. Consumers assume all risk for any products purchased or received from Rotor Riot.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rotor Lab does not provide any warranty, but does provide for a seven day defect period. Rotor Lab has not had any material defects for products sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective September 2025, Unusual Machines, the parent company which manufactures motors has a limited warranty in which it warrants to customers that their products will be free from defects in material and workmanship under normal use and service for up to 90 days. The limited warranty covers manufacturing defects and premature failures and extends only to the original customer and is non-transferrable. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted to $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesCurrent_iI_c20260630__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zfq1e1Q5rau4" title="Accrued liabilities">317,009</span> as of June 30, 2026, and $<span id="xdx_902_eus-gaap--AccruedLiabilitiesCurrent_iI_c20251231__us-gaap--NatureOfExpenseAxis__custom--WarrantLiabilityMember_zmCmUNWgbimj" title="Accrued liabilities">0</span> as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 16207 19602 317009 0 <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zWMmHUjYRq76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zqxOeUB0jELk">Revenue Recognition</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 1: Identify the contract with a customer;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 2: Identify the performance obligations in the contract;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 3: Determine the transaction price;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 4: Allocate the transaction price to the performance obligations in the contract; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Step 5: Recognize revenue when (or as) the Company satisfies a performance obligation at a point in time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company receives revenues from the sale of drone and drone parts to enterprise customers and distributors (“Enterprise Revenue”) and individual consumers (“Retail Revenue”). Revenue is recognized at a point in time when the products are shipped and the price is fixed or determinable, no other significant obligations of the Company exist and collectability is probable. Revenue is recognized when the title to the products has been passed to the customer, which is the date the products are shipped to the customer. This is the date the performance obligation has been met. The Company’s retail return policy allows for certain non-custom or built-to-order products to be returned up to 15 days after the original order is placed so long as it meets specific requirements as outlined in its return policy. The Company’s enterprise return policy allows for returns related to defective product so long as it meets the requirements in its policy. The historical sales returns for retail customers is de minimis and the Company does not have a specific sales return allowance for retail orders. The Company does not have any historical returns for enterprise orders and as such has not recorded a sales returns allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Disaggregation of Revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zIsUeOy71Yfd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span id="xdx_8B1_z8ToMQTW65Lj" style="display: none">Schedule of disaggregated by revenue</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><b>For the Six months Ended</b><br/> <b>June 30</b></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zKQvWbTzKQLf" style="width: 13%; text-align: right" title="Total revenue">3,174,925</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z3lmUIp8Iii3" style="width: 13%; text-align: right" title="Total revenue">2,891,263</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zpCjxq4dTdj" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">21,643,379</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zO85BaeIxDH8" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,275,007</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20260101__20260630_z1BprDcGjwr1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">24,818,304</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250101__20250630_z03kg9U4Mvoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,166,270</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>For the Three months Ended</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>June 30</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Retail revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zHWLPy7nEMr5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">2,392,095</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zecb8KsQBlB5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">1,292,963</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zOJIhJ1ZSW91" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">14,330,372</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zZ09fKlxvZe2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">831,007</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20260401__20260630_zW6XeqYcu2r2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">16,722,467</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20250401__20250630_zsagSjVQITOi" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">2,123,970</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zXAjpyfMWL96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had revenue outside the United States of approximately $<span id="xdx_90B_eus-gaap--Revenues_pn5n6_c20260101__20260630__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zbffKz0nYVgh" title="Foreign sales revenue">1.4</span> million and $<span id="xdx_909_eus-gaap--Revenues_pn5n6_c20250101__20250630__us-gaap--GeographicDistributionAxis__us-gaap--GeographicDistributionForeignMember_zSwfE6Xrmay9" title="Foreign sales revenue">0.2</span> million for the six months ended June 30, 2026 and 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zIsUeOy71Yfd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Disaggregated by revenue)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span id="xdx_8B1_z8ToMQTW65Lj" style="display: none">Schedule of disaggregated by revenue</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><b>For the Six months Ended</b><br/> <b>June 30</b></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Retail revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zKQvWbTzKQLf" style="width: 13%; text-align: right" title="Total revenue">3,174,925</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_z3lmUIp8Iii3" style="width: 13%; text-align: right" title="Total revenue">2,891,263</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20260101__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zpCjxq4dTdj" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">21,643,379</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20250101__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zO85BaeIxDH8" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">1,275,007</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20260101__20260630_z1BprDcGjwr1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">24,818,304</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250101__20250630_z03kg9U4Mvoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">4,166,270</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s revenue disaggregated by revenue type for the period ended:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>For the Three months Ended</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="6" style="font-size: 10pt; text-align: center"><b>June 30</b></td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Retail revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zHWLPy7nEMr5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">2,392,095</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--RetailRevenueMember_zecb8KsQBlB5" style="width: 13%; font-size: 10pt; text-align: right" title="Total revenue">1,292,963</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Enterprise revenue</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20260401__20260630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zOJIhJ1ZSW91" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">14,330,372</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20250401__20250630__srt--ProductOrServiceAxis__custom--EnterpriseRevenueMember_zZ09fKlxvZe2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total revenue">831,007</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20260401__20260630_zW6XeqYcu2r2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">16,722,467</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20250401__20250630_zsagSjVQITOi" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Total revenue">2,123,970</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> 3174925 2891263 21643379 1275007 24818304 4166270 2392095 1292963 14330372 831007 16722467 2123970 1400000 200000 <p id="xdx_840_ecustom--RevenueRecognitionDeferredRevenue1_z4OWFSDlvP5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zyhShGOjQ677">Deferred Revenue</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relates to orders placed and payment received, but not yet fulfilled. All deferred revenue is expected to be recognized within one year. Deferred revenue related to orders placed, but not yet fulfilled totaled $<span id="xdx_905_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20260630_zldJguGKyGWi" title="Deferred revenue, current">286,056</span> and $<span id="xdx_908_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_c20251231_zR92UiokWJ5j" title="Deferred revenue, current">638,125</span> as of June 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 286056 638125 <p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_zO5osorRmYph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zokpXXw3ZpPc">Cost of Goods Sold</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of goods sold includes inventory costs which includes an allocation for labor and rent for our manufactured products, direct packaging costs and production related depreciation, if any. Depreciation included in cost of goods sold for the six months ended June 30, 2026 and 2025 was $<span id="xdx_90F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20260101__20260630_zz9L7TsKegt9" title="Cost of goods sold">74,133</span> and $<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20250101__20250630_z7PRdDtJHaXd" title="Cost of goods sold">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 74133 0 <p id="xdx_849_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zne8ggsNXnUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zl2MCJ220fHl">Shipping and Handling Costs</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs incurred for products shipped to customers are included in operations expenses and amounted to $<span id="xdx_902_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260630__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zlkZTwCqWOFe" title="Shipping and handling costs">722,116</span> and $<span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250630__us-gaap--NatureOfExpenseAxis__custom--ShippingAndHandlingCostsMember_zrQGRsjAZgXg" title="Shipping and handling costs">147,572</span> for the six months ended June 30, 2026 and 2025, respectively. Shipping and handling costs charged to customers are included in sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 722116 147572 <p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_ztqywns3FXVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zwC68emf8gQb">Research and Development</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses include payroll, employee benefits, and other headcount-related expenses associated with product development. Research and development expenses also include third-party development costs, materials, and are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zDayMU5twAm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zPh97nV0LAkl">Income Taxes</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realizable in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zP2uJqjMp16g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86F_zIBpFFQ1gioj">Stock-Based Compensation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock options are valued using the estimated grant-date fair value method of accounting in accordance with ASC Topic 718, Compensation – Stock Compensation. Fair value is determined based on the Black-Scholes Model using inputs reflecting our estimates of expected volatility based on comparative companies through December 31, 2025, and historical volatility beginning of January 1, 2026, expected term using the simplified method and future dividends. The Company recognizes forfeitures as they occur. The fair value of stock grants is based on our stock price on the date of grant. Compensation costs are recognized on a straight-line basis over the requisite service period which is the vesting term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_ecustom--WarrantsPolicyTextBlock_zvmfmWmX8f8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zicUfyC8RCX7">Warrants</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants to purchase shares of its common stock in accordance with the guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). The Company classifies warrants issued for the purchase of shares of its common stock as either equity or liability instruments based on an assessment of the specific terms and conditions of each respective contract. The assessment considers whether the warrants are freestanding financial instruments or embedded in a host instrument, whether the warrants meet the definition of a liability pursuant to ASC 480, whether the warrants meet the definition of a derivative under ASC 815, and whether the warrants meet all of the requirements for equity classification under ASC 815. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants classified as liabilities are recognized as a non-cash gain or loss in the consolidated statements of operations and comprehensive loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zbLKARRCECHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86D_zdsoMpTMgvh2">Foreign Currency</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s wholly owned subsidiary’s functional currency is the Australia dollar (AUD). For financial reporting purposes, the Australia dollar has been translated into the Company’s reporting currency, which is the United States dollar (USD). Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenue and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency translations are included in the statement of operations and comprehensive income (loss) as a component of other comprehensive income (loss). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Transaction gains and losses from transactions denominated in a foreign currency are recognized in other income (expense) in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the cumulative translation adjustments were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_ztNSu2gHrDNk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zeT92sLwqZyj" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_d0_c20260101__20260630_zrxglxgFYAfc" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20260101__20260630_zpPDIjyEGqOa" title="Foreign currency translation adjustment related to Rotor Lab">34,744</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260630_z5zx1pZDwl4j" title="Ending balance">38,214</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z651RQZvUA15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfComprehensiveIncomeLossTableTextBlock_ztNSu2gHrDNk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Cumulative translation adjustments)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zeT92sLwqZyj" style="display: none">Schedule of cumulative translation adjustments</span></td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_d0_c20260101__20260630_zrxglxgFYAfc" title="Beginning balance">3,470</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation adjustment related to Rotor Lab</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c20260101__20260630_zpPDIjyEGqOa" title="Foreign currency translation adjustment related to Rotor Lab">34,744</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_c20260101__20260630_z5zx1pZDwl4j" title="Ending balance">38,214</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3470 34744 38214 <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zuySqQ8EOr4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_z3jc7JKcm9Gl">Net Loss per Share</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per share is calculated based on the weighted-average of common shares outstanding in accordance with FASB ASC Topic 260, <i>Earnings per Share</i>. Diluted net loss per share is calculated based on the weighted-average number of common shares outstanding plus the effect of dilutive potential common shares. When the Company reports a net loss, the calculation of diluted net loss per share excludes potential common shares as the effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic and diluted net income (loss) per common share:</p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJWHDusa9cTc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%"><span id="xdx_8BC_z9rux6wIhe79"><b style="display: none">Schedule of income (loss) per share</b></span></td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_49C_20260101__20260630_z2i7KCpg2UOe" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_491_20250101__20250630_zlc5wib4u3rl" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">For the Six months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Net (loss) income per common share – basic:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_ziDBtNurpvn1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Net (loss) income</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">2,499,441</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(10,231,018</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zOC7car8dkI4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Less: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zsPzJWffxAK6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net (loss) income allocated to common stockholders</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zoYb0Am12S5g" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - basic</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,125,630</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareBasic_zzq9AKqYboM3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - basic</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Net (loss) income per common share – diluted:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zq53zAMheUPg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net (loss) income</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,499,441</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(10,231,018</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zaBBO93jLsif" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Add: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_zPpwkg4aYFd6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Numerator for net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zBzyw4iI4yGi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Weighted average common shares outstanding - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_zL2O6P1rSa2a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income per share of common stock attributable to common stockholders.</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zBupT1norJw2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Reconciliation of basic to diluted weighted average shares)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B2_zjwjthWPiXD6" style="display: none">Schedule of reconciliation of basic to diluted weighted average shares</span> </td><td> </td> <td colspan="3" id="xdx_496_20260101__20260630_ztQbwJq1dV6e" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_492_20250101__20250630_zwg4UgAdWFRi" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Six months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zz4CmDYgD1Ae" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Weighted average shares used in computing net income per share of common stock, basic</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">44,125,630</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">18,853,428</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Add incremental shares:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_zFLgN75i0tUf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Unvested restricted stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zVLgCXnr1Xej" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Stock based awards (options)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">394,889</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zhWhzXdnOLta" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average shares used in computing net income per share of common stock, diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zCgJpa5C58Mk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the potentially dilutive shares that were excluded for the three months ended June 30, 2026, from the computation of diluted net loss per share of common stock attributable to common stockholders, because their effect was anti-dilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zwbcmX4v8j8a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - schedule of antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8BA_zVilvH5YrP9b"><b style="display: none">Schedule of antidilutive shares</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2026</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Unvested stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_zfFXAdv46NPj" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">808,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_z50kJG1jsnki" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">330,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Unvested restricted stock awards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zO2fYgFkNus1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">914,792</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zpcLo9rhjVal" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Representative warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zfrKPadCD8vb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zocsy8qZlSS6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">PIPE warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_zXpBX4RNGZDk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_z3u5yiqPf5Q3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">164,473</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630_zg3HA7ob58I1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">1,723,646</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630_zYz4EUT94pZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">702,973</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zJWHDusa9cTc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Earnings per share)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%"><span id="xdx_8BC_z9rux6wIhe79"><b style="display: none">Schedule of income (loss) per share</b></span></td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_49C_20260101__20260630_z2i7KCpg2UOe" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td><td style="font-size: 10pt; width: 2%"> </td> <td style="font-size: 10pt; text-align: left; width: 1%"> </td><td id="xdx_491_20250101__20250630_zlc5wib4u3rl" style="font-size: 10pt; text-align: right; width: 13%"> </td><td style="font-size: 10pt; text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">For the Six months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Net (loss) income per common share – basic:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_ziDBtNurpvn1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: left">Net (loss) income</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">2,499,441</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(10,231,018</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zOC7car8dkI4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Less: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zsPzJWffxAK6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net (loss) income allocated to common stockholders</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zoYb0Am12S5g" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - basic</td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,125,630</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareBasic_zzq9AKqYboM3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - basic</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; font-weight: bold; text-align: left">Net (loss) income per common share – diluted:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zq53zAMheUPg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net (loss) income</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,499,441</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(10,231,018</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--NetIncomeLossOtherAdjustments_d0_zaBBO93jLsif" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Add: other adjustments</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_zPpwkg4aYFd6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Numerator for net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,499,441</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(10,231,018</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zBzyw4iI4yGi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Weighted average common shares outstanding - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_zL2O6P1rSa2a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Net (loss) income per common share - diluted</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.06</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.54</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr> </table> 2499441 -10231018 0 0 2499441 -10231018 44125630 18853428 0.06 -0.54 2499441 -10231018 0 0 2499441 -10231018 44775513 18853428 0.06 -0.54 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zBupT1norJw2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - Reconciliation of basic to diluted weighted average shares)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B2_zjwjthWPiXD6" style="display: none">Schedule of reconciliation of basic to diluted weighted average shares</span> </td><td> </td> <td colspan="3" id="xdx_496_20260101__20260630_ztQbwJq1dV6e" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_492_20250101__20250630_zwg4UgAdWFRi" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Six months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zz4CmDYgD1Ae" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Weighted average shares used in computing net income per share of common stock, basic</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">44,125,630</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">18,853,428</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Add incremental shares:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d0_zFLgN75i0tUf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Unvested restricted stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">254,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d0_zVLgCXnr1Xej" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Stock based awards (options)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">394,889</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zhWhzXdnOLta" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average shares used in computing net income per share of common stock, diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">44,775,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">18,853,428</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44125630 18853428 254994 0 394889 0 44775513 18853428 <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zwbcmX4v8j8a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of significant accounting policies (Details - schedule of antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8BA_zVilvH5YrP9b"><b style="display: none">Schedule of antidilutive shares</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the<br/> Three months<br/> Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2026</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Unvested stock options</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_zfFXAdv46NPj" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">808,854</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedStockOptionsMember_z50kJG1jsnki" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Antidilutive shares">330,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Unvested restricted stock awards</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zO2fYgFkNus1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">914,792</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockWarrantsMember_zpcLo9rhjVal" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Representative warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zfrKPadCD8vb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RepresentativeWarrantsMember_zocsy8qZlSS6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">8,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">PIPE warrants</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260401__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_zXpBX4RNGZDk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">–</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250401__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PIPEWarrantsMember_z3u5yiqPf5Q3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">164,473</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260401__20260630_zg3HA7ob58I1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">1,723,646</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250401__20250630_zYz4EUT94pZ1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Antidilutive shares">702,973</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 808854 330000 914792 200000 0 8500 0 164473 1723646 702973 <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z0NS1h9DXkvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zG9FChZHh9Rh">Segment Reporting</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Unusual Machines, which sells drones and drone-related components, operates as a <span id="xdx_907_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20260101__20260630_zMHBWfMolUc2" title="Reportable segment::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl1041">single</span></span> reportable segment entity. Our chief operating decision maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Chief Executive Officer is regularly provided with consolidated revenue and expenses consistent with those presented in the consolidated statements of operations and assets and liabilities consistent with those presented in the consolidated balance sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zfF0W5MVUB36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zTxr29iYb4L2">Recent Accounting Pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, the FASB issued ASU No. 2024-03, “Disaggregation of Income Statement Expenses” which requires disaggregated disclosure of income statement expenses into specified categories in disclosures within the footnotes to the financial statements. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, the FASB issued ASU No. 2025-4, “Compensation – Stock Compensation and Revenue From Contracts With Customers” which provides clarifications to share-based consideration payable to a customer. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the effect of this ASU on the consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80A_eus-gaap--AssetAcquisitionTextBlock_zxYzZVhC0ijh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 3 – <span id="xdx_824_zEig30KNX6ak">Acquisitions</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Rotor Lab</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company closed on the acquisition of Rotor Lab. Rotor Lab is an Australian developer and manufacturer of electric motors and propulsion systems for unmanned aerial systems (“UAS”). Its product line includes precision-wound electric motors across multiple classes, from sub-400W units for small UAS to high-power motors supporting large rotary and fixed wing platforms.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the motor production facility in Australia, the Company built out a motor production facility in Orlando, FL and started producing motors for drones in the fourth quarter of 2025. The Company and Rotor Lab have been working together prior to the acquisition on co-developing several motor designs and sizes. The acquisition helps the Company accelerate their goals of building a resilient drone supply chain through their team and technology. In addition, Rotor Lab will continue to serve as the engineering center for the Company’s motor design, prototyping, and low to medium volume production of orders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination was based on a share purchase agreement (the “Rotor Lab Purchase Agreement”) that was executed on June 12, 2025, subject to customary closing conditions and was completed on September 3, 2025. Under the terms of the Rotor Lab Purchase Agreement, the consideration paid for the acquired assets consisted of (i) the issuance of common stock for a value of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn6n6_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__us-gaap--TransactionTypeAxis__custom--RotorLabPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYtFusTxBqs9" title="Stock issued for acquisition, value">4</span>.0 million based on the preceding 20 day average Volume Weighted Average Price (“VWAP”) of the Company’s stock from the date of the signing the Rotor Lab Purchase Agreement in June 2025, and (ii) the issuance of common stock (“Contingent Shares”) for up to a total value of an additional $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pn6n6_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__us-gaap--TransactionTypeAxis__custom--RotorLabPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zywyaSbJkW41">3</span>.0 million based on the Company producing and recognizing revenue, dollar for dollar related to internally manufactured motors during the first two years after the acquisition closing date. The Contingent Shares will be calculated and issued based on the Company’s VWAP for the preceding 20 days on each anniversary date of the closing of the transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The acquisition met the definition of a business combination under ASC 805, Business Combinations, and therefore the assets acquired, and liabilities assumed are accounted for at fair value. The Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zjUz6Gt5c22e" title="Stock issued for acquisition, shares">656,642</span> shares of its common stock based on the formula as noted above, which resulted in an initial purchase price of $<span id="xdx_90E_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zNKDJdzRNujc" title="Initial purchase price">5,922,911</span> based on the Company’s stock price of $<span id="xdx_90B_eus-gaap--BusinessAcquisitionSharePrice_iI_c20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_z9di7ThIjVH9" title="Initial purchase stock per price">9.02</span> on September 3, 2025, which was the closing date of the acquisition. The contingent purchase price has been initially recorded at $<span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zf2EBqghYBFa" title="Contingent consideration">2,847,000</span>. The fair value of contingent consideration was determined using the Monte-Carlo variable scenario model which values the liability at the measurement date using certain assumptions including the expected revenue over the calculation period, a discount rate applied to revenue projections, the risk-free interest rate over the earnout period and certain estimates and probabilities of different outcomes. The Company updated the estimated contingent consideration from the Rotor Lab acquisition to $<span id="xdx_909_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_pp0p0_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_ztuV3kOvVhHf" title="Contingent consideration">3,000,000</span> as of June 30, 2026 based on actual sales during the period based on management’s updated estimate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such fair value amounts are subject to adjustment during the one-year measurement period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following represents the fair value allocation of Rotor Lab Purchase Price:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zeXihTkpGqt1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Fair value allocation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zTmlxOaFrAol" style="display: none">Schedule of purchase fair value allocation</span></td><td> </td> <td colspan="3" id="xdx_496_20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zyDYeYnBCzB4" style="text-align: center"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_zzZGxXm9q1g2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">93,054</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_z8UKgUko0czd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_z6dUz9Y24qM7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,888</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_zGW8CgI6W0Xe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,843</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_zzmh7wILCFnb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_pp0p0_zEg9Cxli8p2f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Right of use asset – operating</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,524</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_z2BTFuKpi5w4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0_zjnTW5afZNR2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_pp0p0_z4GEr2hNKPy8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Non-Compete Agreements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNames_iI_pp0p0_ztcEYLMn5oW6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pp0p0_zWObMVULwSzl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,193,199</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_zDH2CVLJ7R6k" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,194,965</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0_zo8zWOlIu5Hk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_pp0p0_zadSuhpL7w46" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,666</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_pp0p0_d0_zTbzOOlpcmB9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_pp0p0_zzXeA1v2xcmb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability – current and long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">60,044</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_z20vXkO5cn2l" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">425,054</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Initial consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zTlpVIFxr4fk" style="text-align: right" title="Initial purchase price">5,922,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_z9zTNDSngOje" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Contingent consideration</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,847,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zP3jTPbHSLk9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,769,911</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_ztEIjfnUxiS" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 3, 2025, the Company acquired <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250903__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RotorLabMember_zeCPaG23EU9j" title="Acquired percenatge">100</span>% of the issued shares of Rotor Lab. For U.S. federal income tax purposes, the acquisition is treated as a stock purchase. The Company did not make an election under Section 338 of the Internal Revenue Code. As a result, the tax bases of Rotor Lab’s assets and liabilities carry over from their historical amounts, and no step-up in tax basis was recorded for U.S. tax purposes. Goodwill for tax purposes will be amortized over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zC14rQCFWXak" title="Amortization period">15</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The results of Rotor Lab have been included in the Consolidated Financial Statements from the date of acquisition. Revenue was $<span id="xdx_90E_eus-gaap--Revenues_pp0p0_c20250904__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zLTuQGNpa799" title="Revenues">183,481</span> and net loss was $<span id="xdx_90B_eus-gaap--NetIncomeLoss_pp0p0_c20250904__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zgP28mfBoEqe" title="Net income">80,581</span> from the date of acquisition through December 31, 2025 in the consolidated statement of operations. The table below presents the results as reported by the Company and unaudited pro forma results of the Company, assuming that the acquisition of Rotor Lab occurred at the beginning of each period. The unaudited pro forma results are not necessarily indicative of what actually would have occurred had the acquisition been in effect for the periods presented (in thousands, except per share data):</p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zK4LUbVTuES5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Pro Forma Information)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zzhavhMRBC4h" style="display: none">Schedule of unaudited pro forma results</span></td><td> </td> <td colspan="3" id="xdx_496_20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zNUxvXTbP9Od" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_495_20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__srt--StatementScenarioAxis__srt--ProFormaMember_zLScR9VeTxYl" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_494_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zvk2clswSyYl" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_499_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__srt--StatementScenarioAxis__srt--ProFormaMember_zkn8LxDMVFI8" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Year Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As Reported</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proforma</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As Reported</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proforma</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td></tr> <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_d0_zqyq5SCptvs6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">11,199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">11,721</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">6,019</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionsProFormaGrossProfitLoss_pn3n3_d0_zkSpvmPhlKsc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross profit/(loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,906</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,161</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,546</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,960</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_pn3n3_zvotblSBJSb8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,152</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,399</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16,991</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,962</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaOtherExpense_pn3n3_d0_zn8uof8jBIZ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,922</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,879</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15,002</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,062</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zKTPKvqAwbwe" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,193</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,520</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31,980</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32,024</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--BusinessAcquisitionProFormaEarningsPerShareAbstract_iB_zWLmwYKWt87j" style="vertical-align: bottom; background-color: White"> <td>Net earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pip0_zRiCsctnf3Jg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.74</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.86</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3.84</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4.11</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A9_zaPzH5dEJ1yd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited consolidated pro forma financial information is presented for informational purposes only. The unaudited consolidated pro forma adjustments are based on preliminary estimates, information available and certain assumptions, and may be revised as additional information becomes available. In addition, the unaudited pro forma financial information does not reflect any adjustments for non-recurring items or anticipated synergies resulting from the acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> 4000000 3000000 656642 5922911 9.02 2847000 3000000 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zeXihTkpGqt1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Fair value allocation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zTmlxOaFrAol" style="display: none">Schedule of purchase fair value allocation</span></td><td> </td> <td colspan="3" id="xdx_496_20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zyDYeYnBCzB4" style="text-align: center"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_zzZGxXm9q1g2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">93,054</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_z8UKgUko0czd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,419</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_z6dUz9Y24qM7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,888</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_zGW8CgI6W0Xe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,843</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_zzmh7wILCFnb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,772</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_iI_pp0p0_zEg9Cxli8p2f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Right of use asset – operating</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,524</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_z2BTFuKpi5w4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,266</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0_zjnTW5afZNR2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_pp0p0_z4GEr2hNKPy8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Non-Compete Agreements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">233,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNames_iI_pp0p0_ztcEYLMn5oW6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pp0p0_zWObMVULwSzl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,193,199</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_zDH2CVLJ7R6k" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Total assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,194,965</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_pp0p0_zo8zWOlIu5Hk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_pp0p0_zadSuhpL7w46" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,666</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_pp0p0_d0_zTbzOOlpcmB9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred tax liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,231</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_iI_pp0p0_zzXeA1v2xcmb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease liability – current and long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">60,044</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_z20vXkO5cn2l" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">425,054</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Initial consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20250901__20250903__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zTlpVIFxr4fk" style="text-align: right" title="Initial purchase price">5,922,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_z9zTNDSngOje" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Contingent consideration</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,847,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zP3jTPbHSLk9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,769,911</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 93054 132419 36888 21843 179772 58524 10266 190000 233000 46000 8193199 9194965 92113 183666 89231 60044 425054 5922911 2847000 8769911 1 P15Y 183481 80581 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zK4LUbVTuES5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Acquisitions (Details - Pro Forma Information)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zzhavhMRBC4h" style="display: none">Schedule of unaudited pro forma results</span></td><td> </td> <td colspan="3" id="xdx_496_20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zNUxvXTbP9Od" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_495_20250101__20251231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__srt--StatementScenarioAxis__srt--ProFormaMember_zLScR9VeTxYl" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_494_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zvk2clswSyYl" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_499_20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember__srt--StatementScenarioAxis__srt--ProFormaMember_zkn8LxDMVFI8" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Year Ended</td><td style="font-weight: bold"> </td> <td colspan="7" style="font-weight: bold; text-align: center">For the Year Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As Reported</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proforma</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As Reported</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proforma</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(unaudited)</b></p></td></tr> <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_d0_zqyq5SCptvs6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">11,199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">11,721</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">6,019</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionsProFormaGrossProfitLoss_pn3n3_d0_zkSpvmPhlKsc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross profit/(loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,906</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,161</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,546</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,960</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_pn3n3_zvotblSBJSb8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,152</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,399</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(16,991</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,962</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaOtherExpense_pn3n3_d0_zn8uof8jBIZ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,922</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,879</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15,002</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,062</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zKTPKvqAwbwe" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,193</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(19,520</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31,980</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(32,024</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--BusinessAcquisitionProFormaEarningsPerShareAbstract_iB_zWLmwYKWt87j" style="vertical-align: bottom; background-color: White"> <td>Net earnings per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_pip0_zRiCsctnf3Jg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.74</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.86</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3.84</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4.11</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 11199000 11721000 5565000 6019000 3906000 4161000 1546000 1960000 -25152000 -25399000 -16991000 -6962000 5922000 5879000 -15002000 -25062000 -19193000 -19520000 -31980000 -32024000 -0.74 -0.86 -3.84 -4.11 <p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zhglMtev5RE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 4 – <span id="xdx_82D_zVL6WkHSInSh">Inventories</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist solely of raw materials and finished goods was as follows as of June 30, 2026 and December 31, 2025, respectively.</p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfUtilityInventoryTextBlock_z35BOfmy6rOg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details - Inventories)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_z48BbhfoTok7" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="3" id="xdx_491_20260630_zUCQapelTfka" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49A_20251231_zIk57tzrgbzj" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,<br/> 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterials_iI_d0_maINzYg1_zip6Xdexbeh9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">17,469,622</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">4,232,774</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_maINzYg1_zySzLdwiJpd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,444,710</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,874</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_mtINzYg1_zwVOWFL7PGM9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,914,332</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,316,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zqKV3h8UKsPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company had prepaid deposits for inventory totaling $<span id="xdx_90A_ecustom--PrepaidDepositsForInventory_iI_c20260630_zsyJ9STiS0Jh" title="Prepaid deposits for inventory">20,543,732</span> and $<span id="xdx_903_ecustom--PrepaidDepositsForInventory_iI_c20251231_zoPkFRWfl5X3" title="Prepaid deposits for inventory">9,748,483</span> as of June 30, 2026 and December 31, 2025, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfUtilityInventoryTextBlock_z35BOfmy6rOg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories (Details - Inventories)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_z48BbhfoTok7" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="3" id="xdx_491_20260630_zUCQapelTfka" style="text-align: center"> </td><td> </td> <td colspan="3" id="xdx_49A_20251231_zIk57tzrgbzj" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,<br/> 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterials_iI_d0_maINzYg1_zip6Xdexbeh9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">17,469,622</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">4,232,774</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_maINzYg1_zySzLdwiJpd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,444,710</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,874</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_mtINzYg1_zwVOWFL7PGM9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,914,332</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,316,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 17469622 4232774 4444710 1083874 21914332 5316648 20543732 9748483 <p id="xdx_806_eus-gaap--OtherCurrentAssetsTextBlock_zrLPUhXlX97b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 5 – <span id="xdx_828_zu225SOf1eL8">Other Current Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other current assets included as of:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zKu5JgRKRU7f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other Current Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B7_z9tzKOSWTRG5" style="display: none">Schedule of other current assets</span> </td> <td> </td> <td colspan="2" id="xdx_494_20260630_zxxAidTfh0W5" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20251231_zjxmysFRysXe" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></td> <td> </td></tr> <tr id="xdx_400_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidInsuranceMember_zI2EqpiJYxW5" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid insurance</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,891</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,689</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidBenefitsMember_zANFjTfFZGRf" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid benefits</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,814</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,606</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidOtherMember_zMCnks8t5uQk" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid other</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450,556</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,327</span></td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAssetsCurrent_iTI_pp0p0_zbB7KEmsZJYc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other current assets</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134,261</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,622</span></td> <td> </td></tr> </table> <p id="xdx_8A9_zqCzkyS4wS04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-current other assets primarily include rent security deposits of $<span id="xdx_90B_eus-gaap--OtherAssetsNoncurrent_iI_c20260630__us-gaap--NatureOfExpenseAxis__custom--RentSecurityDepositsMember_zjCUuB1GUzF1" title="Other assets">195,056</span> related to the operating leases for the Orlando, FL facilities and the Rotor Lab facility in Australia as of June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zKu5JgRKRU7f" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other Current Assets (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B7_z9tzKOSWTRG5" style="display: none">Schedule of other current assets</span> </td> <td> </td> <td colspan="2" id="xdx_494_20260630_zxxAidTfh0W5" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20251231_zjxmysFRysXe" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2026</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2025</b></span></td> <td> </td></tr> <tr id="xdx_400_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidInsuranceMember_zI2EqpiJYxW5" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid insurance</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,891</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101,689</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidBenefitsMember_zANFjTfFZGRf" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid benefits</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,814</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,606</span></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--OtherAssetsCurrent_iI_pp0p0_d0_hus-gaap--NatureOfExpenseAxis__custom--PrepaidOtherMember_zMCnks8t5uQk" style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid other</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450,556</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,327</span></td> <td> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAssetsCurrent_iTI_pp0p0_zbB7KEmsZJYc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other current assets</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,134,261</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,622</span></td> <td> </td></tr> </table> 559891 101689 123814 48606 450556 40327 1134261 190622 195056 <p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zQw8Sk4UscIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 6 – <span id="xdx_82E_zUPo9oBlGvNd">Property and Equipment, net</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment consist of assets with an estimated useful life greater than one year. Property and equipment are reported net of accumulated depreciation, and the reported values are periodically assessed for impairment. Property and equipment as of:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zMrKD9Wf9186" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zJVZPl0FJZvf" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,<br/> 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Computer equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zwquf3qmQB33" style="width: 13%; text-align: right" title="Total property and equipment">595,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_ze33MtMq79dh" style="width: 13%; text-align: right" title="Total property and equipment">35,973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor production equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zgzXSl6VIkxa" style="text-align: right" title="Total property and equipment">1,822,730</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_ztNbUeKElG7b" style="text-align: right" title="Total property and equipment">2,083,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1Mk2j508lu4" style="text-align: right" title="Total property and equipment">231,644</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1v5dp1dxd5e" style="text-align: right" title="Total property and equipment">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Tenant improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TenantImprovementsMember_zU4lzc4ymj1d" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">203,574</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TenantImprovementsMember_zeMZsYJIRri6" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">149,280</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630_zSxpKBURbEFb" style="text-align: right" title="Total property and equipment">2,853,137</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_z86csMdD66fh" style="text-align: right" title="Total property and equipment">2,268,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20260630_zChzvANVonrh" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(141,762</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20251231_zIWH3isbf7g8" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(34,716</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260630_zBY4u8axEEwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,711,375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zQ7IvX94cB6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,233,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zBhHISYoixw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense totaled $<span id="xdx_90D_eus-gaap--Depreciation_c20260101__20260630_zoBnpxYzGrTc">97,004</span> and $<span id="xdx_904_eus-gaap--Depreciation_c20250101__20250630_zVmGHap1Kz44">342</span> for the six months ended June 30, 2026 and 2025, respectively. A total of $<span id="xdx_90F_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20260101__20260630_ztq7l2CKc5V9" title="Cost of goods sold">74,133</span> and $<span id="xdx_907_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20250101__20250630_zlsh82w2lF74" title="Cost of goods sold">0</span> of depreciation expense was recorded to cost of goods sold in related to the production of motors for the six months ended June 30, 2026 and 2025, respectively. The Company has paid deposits of approximately $<span id="xdx_90C_eus-gaap--ContractualObligation_iI_pn5n6_c20260630__us-gaap--OtherCommitmentsAxis__custom--MotorEquipmentMember_zdCBGgh0RaXg" title="Contractual obligation">2.8</span> million related to the purchase of motor production equipment and $<span id="xdx_90A_eus-gaap--ContractualObligation_iI_c20260630__us-gaap--OtherCommitmentsAxis__custom--TenantImprovementsMember_zQCYRv9M7SCi" title="Contractual obligation">47,494</span> related to tenant improvements, which is included in Other non-current Assets. These assets are expected to be received and placed into service during the third and fourth quarters of 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zMrKD9Wf9186" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zJVZPl0FJZvf" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,<br/> 2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Computer equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zwquf3qmQB33" style="width: 13%; text-align: right" title="Total property and equipment">595,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_ze33MtMq79dh" style="width: 13%; text-align: right" title="Total property and equipment">35,973</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Motor production equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zgzXSl6VIkxa" style="text-align: right" title="Total property and equipment">1,822,730</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_ztNbUeKElG7b" style="text-align: right" title="Total property and equipment">2,083,354</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1Mk2j508lu4" style="text-align: right" title="Total property and equipment">231,644</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1v5dp1dxd5e" style="text-align: right" title="Total property and equipment">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Tenant improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TenantImprovementsMember_zU4lzc4ymj1d" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">203,574</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TenantImprovementsMember_zeMZsYJIRri6" style="border-bottom: Black 1pt solid; text-align: right" title="Total property and equipment">149,280</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20260630_zSxpKBURbEFb" style="text-align: right" title="Total property and equipment">2,853,137</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20251231_z86csMdD66fh" style="text-align: right" title="Total property and equipment">2,268,607</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20260630_zChzvANVonrh" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(141,762</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20251231_zIWH3isbf7g8" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(34,716</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260630_zBY4u8axEEwd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,711,375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20251231_zQ7IvX94cB6j" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property and equipment, net">2,233,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 595189 35973 1822730 2083354 231644 0 203574 149280 2853137 2268607 141762 34716 2711375 2233891 97004 342 74133 0 2800000 47494 <p id="xdx_806_eus-gaap--LesseeOperatingLeasesTextBlock_zEQOMTdCAlbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 7 – <span id="xdx_821_zAcYENnuwgGe">Operating Leases</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has assumed in the February 2024 business combination of Rotor Riot, a five-year operating lease for approximately 6,900 square feet of warehouse and office space in Orlando, Florida. The lease commenced in November 2023 and expires in October 2028. The Company has valued the ROUA and the associated liability, as of February 16, 2024, at $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20240216__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zQ51CC7sJzb7" title="Operating lease right-of-use asset">378,430</span>. Operating lease expense totaled $<span id="xdx_902_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zOXdYlNcOLcd" title="Operating lease expense">52,572</span> and $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_ztBK4v0dR0v7" title="Operating lease expense">52,572</span>, respectively for the six months ended June 30, 2026 and 2025. A total of $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFloridaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zKuqAcUyCVra" title="Operating lease expense">52,239</span> was recorded to costs of goods sold for the six months ended June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2025, Unusual Machines signed a lease agreement for an additional 17,000 square feet of warehouse/office space in Orlando, FL. This space will be used primarily for motor production. The lease commencement date is August 1, 2025 and currently runs through August 21, 2030. The Company has valued the ROUA and the associated liability, as of August 1, 2025, at $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250801__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zdQ7hd6QQ4f1" title="Operating lease right-of-use asset">973,443</span>. Operating lease expense totaled $<span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zYuf5RDNFb1l" title="Operating lease expense">126,862</span> and $<span id="xdx_90E_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zZusAiSUY9r9" title="Operating lease expense">0</span>, respectively for the six months ended June 30, 2026 and 2025. A total of $<span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--June2025AdditionalSpaceMember_zsTS7Z9F9dbg" title="Cost of goods sold">126,862</span> was recorded to cost of goods sold for the six months ended June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2025, Unusual Machines signed a lease agreement for an additional 25,000 square feet of warehouse/office space in Orlando, FL. This space will be used primarily for order fulfillment and inventory storage. The lease commencement date is December 1, 2025 and currently runs through December 31, 2030. The Company has valued the ROUA and the associated liability, as of December 1, 2025, at $<span id="xdx_906_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20251201__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_zuOrblKRwUye">1,430,522</span>. Operating lease expense totaled $<span id="xdx_901_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_zu9GNW2LeWhi">186,430</span> and $<span id="xdx_90D_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--OrlandoFLMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember__us-gaap--TransactionTypeAxis__custom--October2025AdditionalSpaceMember_zCnEBnoIiTj7">0</span>, respectively for the six months ended June 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 15, 2025, the Company parent entity entered into a three-year operating lease agreement for an additional 4,500 square feet of space in Orlando, FL. This space will be used for headset production. The lease commenced on January 1, 2026 and expires in December 2028. The Company has valued the ROUA and the associated liability, as of January 1, 2026, at $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260102__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zLTAeG645kTc">204,749</span>. Operating lease expense totaled $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zHX0BN2HS9o2">38,633</span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zd1VyoH0JBul">0</span>, respectively for the six months ended June 30, 2026 and 2025. A total of $<span id="xdx_908_eus-gaap--CostOfGoodsAndServicesSold_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFL1Member_zW5CkvL6m82d" title="Cost of goods sold">37,125</span> was recorded to cost of goods sold for the six months ended June 30, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 10, 2025, the Company parent entity entered into a three-year operating lease agreement for an additional 9,125 square feet of space in Orlando, FL. This space will be used as the Company’s corporate headquarters. The lease commenced on February 1, 2026 and expires in February 2029. The Company has valued the ROUA and the associated liability, as of February 1, 2026, at $<span id="xdx_90B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260201__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_zTkSEdcHuhbe" title="Operating lease right-of-use asset">613,657</span>. Operating lease expense totaled $<span id="xdx_902_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_zcCCAXaodMkk" title="Operating lease expense">115,786</span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--OrlandoFL2Member_ztwEPA0TKEx9" title="Operating lease expense">0</span>, respectively for the six months ended June 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has assumed in the acquisition of Rotor Lab on September 3, 2025, a three-year operating lease of warehouse and office space in Canberra, Australia. The leased commenced in May 2024 and expires in April 2027. The Company has valued the ROUA and the associated liability, as of September 3, 2025, at $<span id="xdx_900_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250903__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_z0XZLtyfD9Fg" title="Operating lease right-of-use asset">58,524</span>. Operating lease expense totaled $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20260101__20260630__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zgGwfbcfCvWf" title="Operating lease expense">21,175</span> and $<span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20250101__20250630__srt--StatementGeographicalAxis__custom--CanberraAustraliaMember__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zDTSd5JTehBg" title="Operating lease expense">0</span>, respectively for the six months ended June 30, 2026 and 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has no finance leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a summary of the operating lease right-of-use assets and liabilities at June 30, 2026 and 2025:</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOperatingLeaseRightOfUseTableTextBlock_zNRUQsLU5FQ9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Right-to-use)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zAQoCRTYmY8h" style="display: none">Schedule of operating lease right-of-use</span></td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Operating lease right-of-use assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--OperatingLeaseRightOfUseAssetGross_iI_c20260630_zc41ltzonyJi" style="width: 13%; text-align: right" title="Operating lease right-of-use assets">3,708,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--OperatingLeaseRightOfUseAssetGross_iI_c20250630_zYplhXavWTQj" style="width: 13%; text-align: right" title="Operating lease right-of-use assets">378,430</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_c20260630_zvuA2j5ODuH8" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease right-of-use assets, accumulated amortization">(618,585</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_c20250630_zEyrDfdIF9B" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease right-of-use assets, accumulated amortization">(89,914</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Operating lease right-of-use assets, as of June 30</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260630_zthEZ5ZgcZr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">3,090,057</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250630_z3xjG58a5fk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">288,516</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Operating lease liability</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--OperatingLeaseLiabilityGross_iI_c20260630_z7zyVSYOWJNe" style="text-align: right" title="Operating lease liability">3,708,642</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--OperatingLeaseLiabilityGross_iI_c20250630_zSFfHoKGNV67" style="text-align: right" title="Operating lease liability">378,430</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated reduction</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_c20260630_zcbHUWTAxM8b" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, accumulated reduction">(552,628</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_c20250630_zQTbyA9XQfw9" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, accumulated reduction">(81,099</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Operating lease liability, as of June 30</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_c20260630_zoccBBTEC5Ch" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iI_c20250630_ziSA4fSpV973" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">297,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current operating lease liability</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_z57ewoOw60Sd" style="text-align: right" title="Operating lease liability, current">735,521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20250630_zr34ETXnTDvf" style="text-align: right" title="Operating lease liability, current">73,569</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Non-current operating lease liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260630_zu5em3RrTdg7" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, noncurrent">2,420,493</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20250630_zzwkVTC4yYwf" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, noncurrent">223,762</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630_zkMu0pPNuKqg" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20250630_zEqSBbUGmrj1" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">297,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zHXM8ny1FKk2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of future lease payments required under the lease agreement:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zhTHmdDeGwIb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease maturity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zjHnjIhJjYYk" style="display: none">Schedule of future lease payments</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Future Lease <br/> Payments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Discount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Liability</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 58%; text-align: left">2026</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zGIsJShzkJJk" style="width: 11%; text-align: right" title="Future Lease Payments">524,656</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zGWuiFpwabfl" style="width: 11%; text-align: right" title="Operating Lease Discount">(158,516</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zoeOLco6IGH4" style="width: 11%; text-align: right" title="Operating Lease Liability">366,140</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zILWRHxVQi81" style="text-align: right" title="Future Lease Payments">1,030,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zS7CGjobH8bk" style="text-align: right" title="Operating Lease Discount">(260,975</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zjldtuIAvvNg" style="text-align: right" title="Operating Lease Liability">769,320</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zorBdLdiO0Pa" style="text-align: right" title="Future Lease Payments">1,055,065</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_z4Toe39qTTT3" style="text-align: right" title="Operating Lease Discount">(206,382</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zWcqebttFpp" style="text-align: right" title="Operating Lease Liability">848,683</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_z4KuPmy3g9v3" style="text-align: right" title="Future Lease Payments">703,927</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zJi5WfG3b1Gc" style="text-align: right" title="Operating Lease Discount">(84,939</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zkqeI8opmRf1" style="text-align: right" title="Operating Lease Liability">618,988</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_z2TXTZ0gblQ3" style="border-bottom: Black 1pt solid; text-align: right" title="Future Lease Payments">585,355</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zBGcxmyimNH2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Discount">(32,471</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zEFguj9yvU0g" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Liability">552,884</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20260630_zzngrW6oIezd" style="border-bottom: Black 2.5pt double; text-align: right" title="Future Lease Payments">3,899,298</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630_zG3BYTysI32f" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Discount">(743,284</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_c20260630_zbs7igM02HE4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zKZIPq4Zs5ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zg4cvFJqdCi7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease supplemental information)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zjh3iiBmEfOg" style="display: none">Schedule of supplemental information</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">UMAC</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Rotor Riot</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Rotor Lab</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 58%; text-align: left">Weighted average remaining lease term (in years)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_zjzQz1m5PCu9" title="Weighted average remaining lease term (in years)">4.67</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zHvi1B9y16z4" title="Weighted average remaining lease term (in years)">2.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zYC25OMTy8D2" title="Weighted average remaining lease term (in years)">1.08</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_z0k6fEXycO4e" title="Weighted average discount rate">9.87</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zqeiuNn1pyr6" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zLcRpS7Lrb75" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AB_z12f8JDEyoP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>  </b></p> 378430 52572 52572 52239 973443 126862 0 126862 1430522 186430 0 204749 38633 0 37125 613657 115786 0 58524 21175 0 <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfOperatingLeaseRightOfUseTableTextBlock_zNRUQsLU5FQ9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Right-to-use)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zAQoCRTYmY8h" style="display: none">Schedule of operating lease right-of-use</span></td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Operating lease right-of-use assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--OperatingLeaseRightOfUseAssetGross_iI_c20260630_zc41ltzonyJi" style="width: 13%; text-align: right" title="Operating lease right-of-use assets">3,708,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--OperatingLeaseRightOfUseAssetGross_iI_c20250630_zYplhXavWTQj" style="width: 13%; text-align: right" title="Operating lease right-of-use assets">378,430</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_c20260630_zvuA2j5ODuH8" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease right-of-use assets, accumulated amortization">(618,585</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iNI_di_c20250630_zEyrDfdIF9B" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease right-of-use assets, accumulated amortization">(89,914</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Operating lease right-of-use assets, as of June 30</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20260630_zthEZ5ZgcZr4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">3,090,057</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20250630_z3xjG58a5fk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right-of-use assets">288,516</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Operating lease liability</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--OperatingLeaseLiabilityGross_iI_c20260630_z7zyVSYOWJNe" style="text-align: right" title="Operating lease liability">3,708,642</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--OperatingLeaseLiabilityGross_iI_c20250630_zSFfHoKGNV67" style="text-align: right" title="Operating lease liability">378,430</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated reduction</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_c20260630_zcbHUWTAxM8b" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, accumulated reduction">(552,628</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--OperatingLeaseLiabilityAccumulatedAmortization_iNI_di_c20250630_zQTbyA9XQfw9" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, accumulated reduction">(81,099</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Operating lease liability, as of June 30</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_c20260630_zoccBBTEC5Ch" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiability_iI_c20250630_ziSA4fSpV973" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">297,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current operating lease liability</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260630_z57ewoOw60Sd" style="text-align: right" title="Operating lease liability, current">735,521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20250630_zr34ETXnTDvf" style="text-align: right" title="Operating lease liability, current">73,569</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Non-current operating lease liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260630_zu5em3RrTdg7" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, noncurrent">2,420,493</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20250630_zzwkVTC4yYwf" style="border-bottom: Black 1pt solid; text-align: right" title="Operating lease liability, noncurrent">223,762</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liability</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630_zkMu0pPNuKqg" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20250630_zEqSBbUGmrj1" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">297,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3708642 378430 618585 89914 3090057 288516 3708642 378430 552628 81099 3156014 297331 735521 73569 2420493 223762 3156014 297331 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zhTHmdDeGwIb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease maturity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zjHnjIhJjYYk" style="display: none">Schedule of future lease payments</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Future Lease <br/> Payments</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Discount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Lease <br/> Liability</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 58%; text-align: left">2026</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zGIsJShzkJJk" style="width: 11%; text-align: right" title="Future Lease Payments">524,656</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zGWuiFpwabfl" style="width: 11%; text-align: right" title="Operating Lease Discount">(158,516</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2026Member_zoeOLco6IGH4" style="width: 11%; text-align: right" title="Operating Lease Liability">366,140</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zILWRHxVQi81" style="text-align: right" title="Future Lease Payments">1,030,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zS7CGjobH8bk" style="text-align: right" title="Operating Lease Discount">(260,975</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2027Member_zjldtuIAvvNg" style="text-align: right" title="Operating Lease Liability">769,320</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zorBdLdiO0Pa" style="text-align: right" title="Future Lease Payments">1,055,065</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_z4Toe39qTTT3" style="text-align: right" title="Operating Lease Discount">(206,382</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2028Member_zWcqebttFpp" style="text-align: right" title="Operating Lease Liability">848,683</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2029</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_z4KuPmy3g9v3" style="text-align: right" title="Future Lease Payments">703,927</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zJi5WfG3b1Gc" style="text-align: right" title="Operating Lease Discount">(84,939</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2029Member_zkqeI8opmRf1" style="text-align: right" title="Operating Lease Liability">618,988</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2030</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_z2TXTZ0gblQ3" style="border-bottom: Black 1pt solid; text-align: right" title="Future Lease Payments">585,355</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zBGcxmyimNH2" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Discount">(32,471</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_c20260630__us-gaap--LeaseContractualTermAxis__custom--Year2030Member_zEFguj9yvU0g" style="border-bottom: Black 1pt solid; text-align: right" title="Operating Lease Liability">552,884</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_c20260630_zzngrW6oIezd" style="border-bottom: Black 2.5pt double; text-align: right" title="Future Lease Payments">3,899,298</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_c20260630_zG3BYTysI32f" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Discount">(743,284</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseLiability_iI_c20260630_zbs7igM02HE4" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating Lease Liability">3,156,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 524656 158516 366140 1030295 260975 769320 1055065 206382 848683 703927 84939 618988 585355 32471 552884 3899298 743284 3156014 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--LeaseCostTableTextBlock_zg4cvFJqdCi7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Leases (Details - Lease supplemental information)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zjh3iiBmEfOg" style="display: none">Schedule of supplemental information</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Supplemental Information</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">UMAC</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Rotor Riot</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Rotor Lab</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 58%; text-align: left">Weighted average remaining lease term (in years)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_zjzQz1m5PCu9" title="Weighted average remaining lease term (in years)">4.67</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zHvi1B9y16z4" title="Weighted average remaining lease term (in years)">2.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zYC25OMTy8D2" title="Weighted average remaining lease term (in years)">1.08</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--UMACMember_z0k6fEXycO4e" title="Weighted average discount rate">9.87</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorRiotMember_zqeiuNn1pyr6" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20260630__us-gaap--BusinessAcquisitionAxis__custom--RotorLabMember_zLcRpS7Lrb75" title="Weighted average discount rate">11.49</span>%</td><td style="text-align: left"> </td></tr> </table> P4Y8M1D P2Y6M29D P1Y29D 0.0987 0.1149 0.1149 <p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zeYYxGdipf9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 8 – <span id="xdx_82E_zEdKc28EClQl">Goodwill and Intangible Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Goodwill</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no changes in the carrying amount of goodwill during the six months ending June 30, 2026. The carrying value of goodwill was $<span id="xdx_909_eus-gaap--Goodwill_iI_c20260630_z7nLFDogNzUk" title="Goodwill">15,596,105</span> and $<span id="xdx_902_eus-gaap--Goodwill_iI_c20251231_z0xlgUW98XC2" title="Goodwill">15,596,105</span> as of June 30, 2026 and December 31, 2025 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Intangible Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2026, the balances of intangible assets were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zvoIJES2Nbg7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zjjeIgoRwqo5" style="display: none">Schedule of intangible assets</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Value</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents/IP – Fat Shark</span></td> <td style="width: 2%"> </td> <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zNkho6tAg1bh" style="width: 13%; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">824,857</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zvpwyJuCLXFd" style="width: 13%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194,008</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zLfZ63BkMo1f" style="width: 13%; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">630,849</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark – Rotor Riot</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite-lived</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zBOcrVZuerM4" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,130</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zphCl9RqPxsi" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,130</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade name – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zEOsGe4zxP8g" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zfjtZ1oXKS89" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,667</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z0dk2coEdjTg" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,333</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxDxoOgKX5s6" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSQUcql6Se47" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,619</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfbiDUS1kMIl" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,381</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Compete Agreements – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z2vAlOpzuJu5" style="border-bottom: black 1pt solid; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zD6QBwS6c5Ri" style="border-bottom: black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,083</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zpmhz3bYGHd4" style="border-bottom: black 1pt solid; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,917</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630_zlRPRzykNpmi" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,773,987</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630_zLc7QSC2hATf" style="border-bottom: black 2.25pt double; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(321,377</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630_zGXyWEkDRTgf" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,452,610</span></td> <td> </td></tr> </table> <p id="xdx_8A7_z1aazrhsMqe9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patents and intellectual property relate to the patents and technology know-how from the acquisition of Fat Shark in February 2024. Patents are amortized over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zqkWKvgwo5L8" title="Intangible asset, amortization period">10</span> years. Trademarks relate to the brand name and recognition of Rotor Riot from the acquisition in February 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade name for Rotor Lab is amortized over <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RotorLabMember_zgB94I914BUg" title="Intangible asset, amortization period">5</span> years, customer relationships are amortized over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zBLwYmMeOV89" title="Intangible asset, amortization period">7</span> years and non-compete agreements are amortized over <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z33RDE3bWqfd" title="Intangible asset, amortization period">2</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for the six months ended June 30, 2026 and 2025 was $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20260101__20260630_zblGMVpX0jp5" title="Amortization expense">117,265</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20250101__20250630_zjzl0NBegjxd" title="Amortization expense">40,841</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> 15596105 15596105 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zvoIJES2Nbg7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zjjeIgoRwqo5" style="display: none">Schedule of intangible assets</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Value</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents/IP – Fat Shark</span></td> <td style="width: 2%"> </td> <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zNkho6tAg1bh" style="width: 13%; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">824,857</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zvpwyJuCLXFd" style="width: 13%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194,008</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zLfZ63BkMo1f" style="width: 13%; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">630,849</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark – Rotor Riot</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite-lived</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zBOcrVZuerM4" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,130</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_c20260630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zphCl9RqPxsi" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,130</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade name – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zEOsGe4zxP8g" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zfjtZ1oXKS89" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,667</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z0dk2coEdjTg" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,333</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxDxoOgKX5s6" style="text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSQUcql6Se47" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,619</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zfbiDUS1kMIl" style="text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,381</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Compete Agreements – Rotor Lab</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z2vAlOpzuJu5" style="border-bottom: black 1pt solid; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zD6QBwS6c5Ri" style="border-bottom: black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,083</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zpmhz3bYGHd4" style="border-bottom: black 1pt solid; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,917</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20260630_zlRPRzykNpmi" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible assets, gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,773,987</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20260630_zLc7QSC2hATf" style="border-bottom: black 2.25pt double; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(321,377</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20260630_zGXyWEkDRTgf" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,452,610</span></td> <td> </td></tr> </table> 824857 194008 630849 1480130 1480130 46000 7667 38333 190000 22619 167381 233000 97083 135917 2773987 321377 2452610 P10Y P5Y P7Y P2Y 117265 40841 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zrpX2EivhZl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 9 – <span id="xdx_820_zbYralv68lO6">Stockholders’ Equity</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Common Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">2026 Transactions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock for services issued to employees and directors</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 2, 2026, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260101__20260102__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_z1jUQ3i5Xm93" title="Restricted stock issued, shares">70,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $13.57 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20260101__20260102__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zd3gMDHZXDeb" title="Share-based compensation">949,900</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2026, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260122__20260123__srt--CounterpartyNameAxis__custom--ExecutiveOfficersMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zl3iySE3rOd3">550,000</span> restricted shares of common stock to executive officers of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to executive officers are subject to pro rata forfeiture through December 31, 2026. The shares were valued at $16.70 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260122__20260123__srt--CounterpartyNameAxis__custom--ExecutiveOfficersMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zqxhLR5DRhob" title="Restricted stock granted, value">9,185,000</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2026, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260122__20260123__srt--CounterpartyNameAxis__custom--CertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_zpIjQDKWBZLc" title="Restricted stock granted, shares">120,000</span> restricted shares of common stock to certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $16.70 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260122__20260123__srt--CounterpartyNameAxis__custom--CertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January232026IssuanceMember_z2bnJFmki279">2,004,000</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2026, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260312__20260313__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zODH2nWLh3p8">5,883</span> shares of common stock related to vested restricted stock units for our certain board members. The restricted stock units are valued at $20.40 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260312__20260313__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zlzjEmWBZuyi">120,013</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 20, 2026, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20260519__20260520__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_z8NgVdPtMwEd" title="Restricted stock granted, shares">8,352</span> shares of common stock related to vested restricted stock units for our certain board members. The restricted stock units are valued at $14.37 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260519__20260520__srt--CounterpartyNameAxis__custom--CertainBoardMembersMember_zaE5kPIHkSi8" title="Restricted stock granted, shares">120,018</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Common stock issued for services to non-employees</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 2, 2026, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260101__20260102__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zI6xtUxIl0og" title="Stock issued for services, shares">40,000</span> restricted shares of common stock to a consultant for service performed. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to the consultant are subject to pro-rata forfeiture over a two-year period. The shares were valued at $13.57 per share, which was the quoted trading price of the Company’s common stock on the date of grant, respectively, for a total of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260102__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2026IssuanceMember_zoEeU9Z7oLag" title="Stock issued for services, value">542,800</span> to be recognized as stock compensation expense pro-rata over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2026, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20260521__20260522__srt--CounterpartyNameAxis__custom--CommonSharesIssuedForServicesMember_z0MDchjVupnc" title="Restricted stock granted, shares">108,000</span> shares of common stock related to vested restricted stock units for our advisory board members. The restricted stock units are valued at $16.78 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260521__20260522__srt--CounterpartyNameAxis__custom--CommonSharesIssuedForServicesMember_zhnFjeatfPZ4" title="Restricted stock granted, shares">1,812,240</span> and expensed on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to option exercises</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026, several employees of the Company exercised 120,830 of their vested stock options in which the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260630__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_z6JG2iYE8Vza" title="Stock issued for options exercised">120,830</span> shares of common stock related to these exercises. The Company received total cash proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromStockOptionsExercised_c20260101__20260630__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zHXVNVwtqKui" title="Proceeds from options exercised">587,585</span> related to the exercise of the stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to warrant exercises</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2026 the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260108__20260109_zoxi4ul93jDf" title="Stock issued for warrant exercises, shares">350,000</span> shares of common stock related to warrant holders exercising their warrants. The Company received gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromWarrantExercises_c20260108__20260109_z5M20rxV0gWi" title="Proceeds from warrant exercises">3,395,000</span> related to the warrant exercises. The Company cancelled the 350,000 warrants upon issuance of the common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Common stock issued related to public offering</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 19, 2026, in a confidentially marketed public offering the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zy7oD17FQHRf" title="Stock issued new, shares">8,823,529</span> shares of common stock at $17.00 per share resulting in gross proceeds of $<span id="xdx_90D_ecustom--GrossProceedsFromIssuanceOfCommonStock_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zcBqu1hZT1h2" title="Gross proceeds from issuance of common stock">149,999,993</span>, prior to the payment of placement fees of $<span id="xdx_904_eus-gaap--PaymentsOfStockIssuanceCosts_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--PlacementAgentFeesMember_zfkKssMbeql2" title="Payments of stock issuance costss">10,500,000</span> and $<span id="xdx_904_eus-gaap--PaymentsOfStockIssuanceCosts_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--OtherOfferingExpensesMember_zX1zIaHEELab" title="Payments of stock issuance costss">700,000</span> of other offering expenses resulting in net proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260318__20260319__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zGkbc0oUCnBa" title="Proceeds from issuance of common stock">138,799,993</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 29, 2026, we completed an at the market offering for the sale of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_z8GT3KdYufLb" title="Stock issued new, shares">2,000,000</span> shares of Common Stock at a price of $30.00 per share for aggregate gross proceeds of approximately $<span id="xdx_90D_ecustom--GrossProceedsFromIssuanceOfCommonStock_pn6n6_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_zvbtN3EK3Qaa" title="Gross proceeds from issuance of common stock">60</span>.0 million before deducting fees to the placement agent and other expenses payable by us in connection with the offering. The Company retained approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20260528__20260529__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketOfferingMember_zrunhNbyHhNh" title="Proceeds from issuance of common stock">58.2</span> million in net proceeds after offering expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">2025 Transactions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 14, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250113__20250114__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2025IssuanceMember_zpc4WRsG1tvf" title="Restricted stock issued, shares">3,546</span> immediately vested restricted shares of common stock to non-employee directors of the Company. The shares of restricted stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $11.99 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20260113__20260114__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--January2025IssuanceMember_zP3i9RcIuQ56" title="Share-based compensation">42,517</span> to be recognized as stock compensation expense on the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 3, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250202__20250203__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zEsSDO2t7uW5" title="Restricted stock issued, shares">480,000</span> restricted shares of common stock to executive officers and certain employees of the Company. The shares of restricted stock were granted under the Company’s 2022 Equity Incentive Plan. The restricted shares issued to executive officers are subject to pro rata forfeiture through December 31, 2025. The restricted shares issued to certain employees are subject to pro-rata forfeiture over a four-year period. The shares were valued at $12.00 per share, which was the value of the Company’s common stock on the date of grant, respectively for a total of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20250202__20250203__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zjc5wLA5g7Qi" title="Restricted stock granted, value">5,760,000</span> to be recognized as stock compensation expense pro-rata over the vesting period. Stock compensation expense of $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20250101__20251231__srt--CounterpartyNameAxis__custom--ExecutiveOfficersAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--February2025IssuanceMember_zJxYyme6TjUc" title="Share based compensation">5,007,742</span> was recognized during the year ended December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2025, the Company issued <span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zFT8s3pOkUh6" title="Conversion of stock, shares issued">1,224,606</span> shares of common stock related to warrant holders exercising their warrants at an exercise price of $<span id="xdx_900_eus-gaap--WarrantExercisePriceIncrease_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzzazN3hpfl8" title="Exercise price">1.99</span>. The Company received gross proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromWarrantExercises_c20250201__20250228_zZbM4ZNpcEg4" title="Proceeds related to warrant exercises">2,436,966</span> related to the warrant exercises. The Company cancelled the <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20250201__20250228__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantExercisesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZUVLkUfJnI" title="Conversion of stock, shares converted">1,224,606</span> warrants upon issuance of the common shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6, 2025, in a confidentially marketed public offering the Company sold <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zskMLILNtIs7" title="Stock issued new, shares">8,000,000</span> shares of common stock at $5.00 per share resulting in gross proceeds of $<span id="xdx_903_ecustom--GrossProceedsFromIssuanceOfCommonStock_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zKGp4fSrh226" title="Gross proceeds from issuance of common stock">40,000,000</span>, prior to payment of placement agent fees of $<span id="xdx_905_eus-gaap--PaymentsOfStockIssuanceCosts_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--PlacementAgentFeesMember_zS4f5sTIjP75" title="Payments of stock issuance costss">3,200,000</span> and $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember__us-gaap--TransactionTypeAxis__custom--OtherOfferingExpensesMember_zcmRTjBrNbx2" title="Payments of stock issuance costss">304,000</span> of other offering expenses resulting in net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250505__20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zn350z0lmoza" title="Proceeds from issuance of common stock">36,496,000</span>. Dominari Securities, LLC acted as the sole placement agent and also received a warrant to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250506__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zXMFwyOUvAml" title="Received warrant shares">640,000</span> shares of the Company’s common stock at $5.00 per share over a two-year period expiring on May 6, 2027.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250518__20250519__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_zXA5QmHIk1N9" title="Restricted stock issued, shares">33,336</span> immediately vested restricted shares of common stock to non-employee directors of the Company. The shares of restricted stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $5.40 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of approximately $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20250101__20250630__srt--CounterpartyNameAxis__custom--NonEmployeeDirectorsMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_z5Eg1BLbNZUh" title="Share-based compensation">180,000</span> to be recognized as stock compensation expense during the six months ended June 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2025, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250518__20250519__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_zVXHPFDlFgx4" title="Restricted stock issued, shares">4,630</span> immediately vested shares of common stock to a consultant of the Company related to services provided. The shares of common stock were granted under the 2022 Equity Incentive Plan. The shares were valued at $5.40 per share, which was the value the Company’s common stock on the date of grant, respectively for a total of approximately $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20250101__20250630__srt--CounterpartyNameAxis__custom--ConsultantMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member__us-gaap--TransactionTypeAxis__custom--May2025IssuanceMember_zXY9c8x6igpg" title="Share-based compensation">25,000</span> to be recognized as stock compensation expense during the six months ended June 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250521__20250522__srt--CounterpartyNameAxis__custom--AdvisoryBoardMembersMember_zJMS3GDhbJ1e" title="Restricted stock granted, shares">150,000</span> shares of common stock related to vested restricted stock units for our advisory board members. The restricted stock units are valued at $4.40 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260521__20260522__srt--CounterpartyNameAxis__custom--AdvisoryBoardMembersMember_z3FAyFiZEBv5" title="Restricted stock granted, shares">660,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2025, several employees of the Company exercised <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20250101__20250630__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zfmN2F3DbMFf" title="Options exercised, shares">94,650</span> of their vested stock options in which the Company issued 94,650 shares of common stock related to these stock option exercises. The Company received total cash proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromStockOptionsExercised_c20250101__20250630__srt--CounterpartyNameAxis__custom--SeveralEmployeesMember_zXw4h7jOHEZi" title="Proceeds from options exercised">367,870</span> related to the exercise of these options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2025, the Board of Directors of the Company awarded the Company’s Chief Executive Officer <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250629__20250630__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zTjVBDqhrGA9" title="Restricted stock issued, shares">175,000</span> restricted shares of the Company’s common stock under the 2022 Equity Incentive Plan as a bonus related to the May 2025 public offering. The restricted shares are valued at $8.57 per share, the closing price of our common stock as of the date of the grant, for a total value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250629__20250630__srt--CounterpartyNameAxis__srt--ChiefExecutiveOfficerMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zEP5242LiZ9d" title="Restricted stock issued, value">1,499,750</span> that was recognized immediately based on the vesting of the awards for each of the Company’s Officers. The shares are subject to the Company’s clawback policy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 70000 949900 550000 9185000 120000 2004000 5883 120013 8352 120018 40000 542800 108000 1812240 120830 587585 350000 3395000 8823529 149999993 10500000 700000 138799993 2000000 60000000 58200000 3546 42517 480000 5760000 5007742 1224606 1.99 2436966 1224606 8000000 40000000 3200000 304000 36496000 640000 33336 180000 4630 25000 150000 660000 94650 367870 175000 1499750 <p id="xdx_802_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zWaPvPGqq4f5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Note 10 – <span id="xdx_828_z9uwvWwPK7g5">Share Based Awards</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Board of Directors has delegated authority to the Chief Executive Officer to grant stock options to employees who are not executive officers. Any issuance of restricted stock awards or restricted stock units must be approved by the Company’s Compensation Committee. Stock options are granted for employees on a monthly to quarterly basis. Restricted stock awards and restricted stock units are granted on a quarterly basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Stock Options</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan allows the Company to incentivize key employees and directors with long term compensation awards such as stock options, restricted stock, and other similar types of awards. The Plan is authorized to issue up to 15% of the outstanding shares on a fully diluted basis giving effect to the exercise and conversion of all outstanding common stock equivalents issued outside of the Plan. In addition, the Plan has an “evergreen” provision, pursuant to which the number of shares of common stock reserved for issuance pursuant to awards under such plan shall be increased on the first day of each year beginning in 2025 and ending in 2032 equal to the lesser of (a) five percent (5%) of the shares of stock outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (b) such smaller number of shares of stock as determined by our board of directors. The Plan allows for awards to be issued up to a contractual maximum term of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zTYrGLphD8Ba" title="Contractual maximum term">10</span> years from the grant date. As of June 30, 2026, the Plan is authorized to issue up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20260630_zxKMQvL506n9" title="Authorized shares">9,283,338</span> of awards, with <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20260630_zRHqgfMBehE" title="Shares available for issuance">3,779,601</span> shares available for issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2026 and 2025, the Company’s Board of Directors approved the grant of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--CounterpartyNameAxis__custom--CertainEmployeesMember_zSKG1SiXa1kj">280,000</span> and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--CounterpartyNameAxis__custom--CertainEmployeesMember_z0FR3UgpUQDl">177,500</span>, respectively of stock options under the Plan to certain employees. The stock options are subject to certain vesting provisions. Standard vesting on stock options have a six-month cliff vesting in which the first two quarters vest at the six-month mark and quarterly thereafter over a total of four years, however, certain stock options may have immediate vesting or shorter periods as approved. Stock options contractual term range from 5 to 10 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the activity for stock options outstanding:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zuwXq9LdUDlc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Stock options activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_z5diyCabxWhc" style="display: none">Schedule of stock option activity</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Non-Qualified</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Options</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual Term</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic Value</b></p></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding - December 31, 2025</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zkahx9XZLez2" style="width: 13%; text-align: right" title="Non-Qualified options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">739,684</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9rLfaU01v09" style="width: 13%; text-align: right" title="Weighted average exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.54</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm1_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOu74qFrHCa" title="Weighted average remaining contractual term">4.49</span></span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zg5hT2oHjId" style="width: 13%; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9olhFw9Lw58" style="text-align: right" title="Non-Qualified options, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfa89EgW9MYi" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.74</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9rxqTWMACib" style="text-align: right" title="Non-Qualified options, forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zE0wCF5DsVJ1" style="text-align: right" title="Weighted average exercise price, forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpT3u0ryZ9Sg" style="border-bottom: black 1pt solid; text-align: right" title="Non-Qualified options, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,830</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zv7hNfTLi8re" style="border-bottom: black 1pt solid; text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.86</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqrAhBwY51L6" style="border-bottom: black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding – June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zt6QTSYv2Bni" style="border-bottom: black 2.25pt double; text-align: right" title="Non-Qualified options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">808,854</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zCdzgInvcSaj" style="border-bottom: black 2.25pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.85</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYWjH8DxUrua" title="Weighted average remaining contractual term">5.29</span></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zraGyHCBQwol" style="border-bottom: black 2.25pt double; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,815,072</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable – June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLgp3v8sl6rb" style="border-bottom: black 2.25pt double; text-align: right" title="Non-Qualified options, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,687</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPZimXhQXKr7" style="border-bottom: black 2.25pt double; text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.51</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPloOk8ro4bc" title="Weighted average remaining contractual term, exercisable">6.21</span></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z84az2VsOLqg" style="border-bottom: black 2.25pt double; text-align: right" title="Aggregate intrinsic value, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">535,276</span></td> <td> </td></tr> </table> <p id="xdx_8A8_zU9kCISI5tpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The range of assumptions used to calculate the fair value of options granted during the period ended June 30, 2026 was:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjv72sOVkBoi" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Based Awards (Details - Stock options assumptions)"> <tr style="vertical-align: bottom"> <td style="width: 81%"><span id="xdx_8B4_zQ4bLXiSfXQ8" style="display: none">Schedule of stock options assumptions</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zTow4h1GCLXh" title="Exercise price">12.34</span> - <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z3SUjFrb7Ubg" title="Exercise price">16.70</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price on date of grant</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zhv1R9ZoYlca">12.34</span> - <span id="xdx_900_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zXZQLRJwsrnk" title="Stock price on date of grant">16.70</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zswV7Pwmo4P8">3.72</span>% – <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zk2CoVzCmnR2" title="Risk-free interest rate">3.88</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjnM6DBKs0J5" title="Dividend yield">–</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_za9A4dJhC3B2" title="Expected term (years)">3.57</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zFV33dnlg5M8" title="Volatility">149.99</span>% – <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zMjCc8ZD2c8l" title="Volatility">151.22</span>%</span></td> <td> </td></tr> </table> <p id="xdx_8AA_zPtjqRdKNypg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total grant date fair value of stock options granted was $<span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedValue_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPZTHT15fKi" title="Options granted, value">3,290,306</span> and $<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedValue_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJuJW8WU0tU3" title="Options granted, value">814,485</span> during the six months ended June 30, 2026 and 2025, respectively. The Company recognized $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2c1y7W4ha4c" title="Stock-based compensation expense">657,213</span> and $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNXrIU5ldEM4" title="Stock-based compensation expense">599,771</span> in stock-based compensation expense related to stock options during the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, there was $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20260630__us-gaap--AwardTypeAxis__custom--UnvestedStockOptionsMember_z254hT5cSGh" title="Unrecognized stock-based compensation expense">4,960,077</span> of unrecognized stock-based compensation expense related to unvested stock options to be recognized over the remaining vesting term through 2030.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Restricted Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Restricted stock awards are equity grants in which the Company issues restricted common stock awards as of the grant date which are subject to certain vesting and clawback provisions. Restricted stock units are equity grants in which the Company issues a restricted stock unit subject to vesting requirements and common stock is not issued until the vesting requirements have been met. The following table presents the activity for restricted stock awards and restricted stock units outstanding:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zV6c1oFD4jG2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Restricted stock)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zEL9ui4TW933" style="display: none">Schedule of restricted stock activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted Stock<br/> Awards</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date <br/> Fair Value - RSA</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted <br/> Stock Units</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value - RSU</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Unvested - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zddXYPnEKhp8" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziSYR8FsiFEh" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">9.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zK4ufbNlU6A7" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJddGYJxSqXd" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOQ3cEbKWZ92" style="text-align: right" title="Restricted stock, granted">794,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcVCjTuHzhb3" style="text-align: right" title="Weighted average grant date, granted">16.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDccdlrItJwl" style="text-align: right" title="Restricted stock, granted">108,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRnYbqPXvhn" style="text-align: right" title="Weighted average grant date, granted">16.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zbFcbGZs5J74" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zINKV8aubial" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAFt0j3Bea41" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7K0UkxMkZf2" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zg8CCZEupHE9" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(404,443</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zJKQz5fH1Ps2" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">13.70</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLeYYxZZN3wd" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(108,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYsQgO3S4eqg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">16.78</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Unvested – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjadGico0lw3" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">914,792</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z55ok74lsmXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">13.07</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1Bs60GxPdzi" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6vjMhSjE8ed" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zCKVaxpqPNZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total value of restricted stock and restricted stock units was $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zYEYmVg2QoFf" title="Value of restricted stock and restricted stock units granted">14,733,972</span> and $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvugw46RHo36" title="Value of restricted stock and restricted stock units granted">9,392,782</span> granted during the six months ended June 30, 2026 and 2025, respectively. The Company recognized $<span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zmkOECFOwLhh" title="Stock-based compensation expense">8,928,327</span> and $<span id="xdx_90E_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zt0CxqzQXnib" title="Stock-based compensation expense">6,819,929</span> in stock-based compensation expense related to restricted stock and restricted stock units during the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, there was $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20260630__us-gaap--AwardTypeAxis__custom--UnvestedRestrictedStockMember_zeht9oFsn4u4" title="Unrecognized stock-based compensation expense">10,519,323</span> of unrecognized stock-based compensation expense related to unvested restricted stock to be recognized over the remaining vesting term through 2030.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Warrants</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the activity for warrants outstanding as of June 30, 2026:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zeNrjih7LKAh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zTWs5gFUTugf" style="display: none">Schedule of warrant activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630_zXjo6zIhFV44" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630_zn0tljTKeiJ" style="width: 13%; text-align: right" title="Weighted average exercise price warrants outstanding, beginning balance">9.70</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630_zcCjd8LKHYD9" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zSmKA0MssfC8" style="text-align: right" title="Weighted average exercise price warrants, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/cancelled/restored</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_d0_c20260101__20260630_z8W71fPrRYyc" style="text-align: right" title="Warrants forfeited/cancelled/restored">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zbxWldhulOm4" style="text-align: right" title="Weighted average exercise price warrants, forfeited/cancelled/restored">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260630_zMM1Si1wg8Ei" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(350,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_c20260101__20260630_ztufO3O6bJJh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price warrants, exercised">9.70</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20260101__20260630_zRTF5W5VPMp2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20260101__20260630_zVcrs9cqImu7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zHoe3YWyBgV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2026, <span id="xdx_90E_ecustom--WarrantsExercisedDuringPeriod_c20260108__20260109_zffzpcupVApi" title="Warrant exercised">350,000</span> warrants were exercised related to the July 2025 Registered Direct Offering and the Company received proceeds of $<span id="xdx_906_eus-gaap--ProceedsFromWarrantExercises_c20260101__20260630_zpglLeRcQzm6" title="Proceeds from warrant exercises">3,395,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> P10Y 9283338 3779601 280000 177500 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zuwXq9LdUDlc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Stock options activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_z5diyCabxWhc" style="display: none">Schedule of stock option activity</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Non-Qualified</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Options</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual Term</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic Value</b></p></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding - December 31, 2025</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zkahx9XZLez2" style="width: 13%; text-align: right" title="Non-Qualified options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">739,684</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9rLfaU01v09" style="width: 13%; text-align: right" title="Weighted average exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.54</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm1_dtY_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOu74qFrHCa" title="Weighted average remaining contractual term">4.49</span></span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_d0_c20251231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zg5hT2oHjId" style="width: 13%; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9olhFw9Lw58" style="text-align: right" title="Non-Qualified options, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfa89EgW9MYi" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.74</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9rxqTWMACib" style="text-align: right" title="Non-Qualified options, forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zE0wCF5DsVJ1" style="text-align: right" title="Weighted average exercise price, forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpT3u0ryZ9Sg" style="border-bottom: black 1pt solid; text-align: right" title="Non-Qualified options, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,830</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zv7hNfTLi8re" style="border-bottom: black 1pt solid; text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.86</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqrAhBwY51L6" style="border-bottom: black 1pt solid; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding – June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zt6QTSYv2Bni" style="border-bottom: black 2.25pt double; text-align: right" title="Non-Qualified options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">808,854</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zCdzgInvcSaj" style="border-bottom: black 2.25pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.85</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYWjH8DxUrua" title="Weighted average remaining contractual term">5.29</span></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zraGyHCBQwol" style="border-bottom: black 2.25pt double; text-align: right" title="Aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,815,072</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable – June 30, 2026</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zLgp3v8sl6rb" style="border-bottom: black 2.25pt double; text-align: right" title="Non-Qualified options, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,687</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPZimXhQXKr7" style="border-bottom: black 2.25pt double; text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.51</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPloOk8ro4bc" title="Weighted average remaining contractual term, exercisable">6.21</span></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z84az2VsOLqg" style="border-bottom: black 2.25pt double; text-align: right" title="Aggregate intrinsic value, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">535,276</span></td> <td> </td></tr> </table> 739684 6.54 P4Y5M26D 0 280000 13.74 90000 10.47 120830 4.86 -0 808854 8.85 P5Y3M14D 2815072 77687 5.51 P6Y2M15D 535276 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zjv72sOVkBoi" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share Based Awards (Details - Stock options assumptions)"> <tr style="vertical-align: bottom"> <td style="width: 81%"><span id="xdx_8B4_zQ4bLXiSfXQ8" style="display: none">Schedule of stock options assumptions</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2026</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zTow4h1GCLXh" title="Exercise price">12.34</span> - <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_z3SUjFrb7Ubg" title="Exercise price">16.70</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Price on date of grant</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zhv1R9ZoYlca">12.34</span> - <span id="xdx_900_eus-gaap--SharePrice_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zXZQLRJwsrnk" title="Stock price on date of grant">16.70</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zswV7Pwmo4P8">3.72</span>% – <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zk2CoVzCmnR2" title="Risk-free interest rate">3.88</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjnM6DBKs0J5" title="Dividend yield">–</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_za9A4dJhC3B2" title="Expected term (years)">3.57</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zFV33dnlg5M8" title="Volatility">149.99</span>% – <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zMjCc8ZD2c8l" title="Volatility">151.22</span>%</span></td> <td> </td></tr> </table> 12.34 16.70 12.34 16.70 0.0372 0.0388 0 P3Y6M25D 1.4999 1.5122 3290306 814485 657213 599771 4960077 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zV6c1oFD4jG2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Restricted stock)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B6_zEL9ui4TW933" style="display: none">Schedule of restricted stock activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted Stock<br/> Awards</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date <br/> Fair Value - RSA</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restricted <br/> Stock Units</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value - RSU</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Unvested - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zddXYPnEKhp8" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">525,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziSYR8FsiFEh" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">9.67</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zK4ufbNlU6A7" style="width: 13%; text-align: right" title="Restricted stock outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJddGYJxSqXd" style="width: 13%; text-align: right" title="Weighted average grant date, beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOQ3cEbKWZ92" style="text-align: right" title="Restricted stock, granted">794,235</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcVCjTuHzhb3" style="text-align: right" title="Weighted average grant date, granted">16.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDccdlrItJwl" style="text-align: right" title="Restricted stock, granted">108,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRnYbqPXvhn" style="text-align: right" title="Weighted average grant date, granted">16.78</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/canceled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zbFcbGZs5J74" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zINKV8aubial" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAFt0j3Bea41" style="text-align: right" title="Restricted stock, forfeited/cancelled">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7K0UkxMkZf2" style="text-align: right" title="Weighted average grant date, forfeited/canceled">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zg8CCZEupHE9" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(404,443</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zJKQz5fH1Ps2" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">13.70</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLeYYxZZN3wd" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock, vested">(108,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYsQgO3S4eqg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date, vested">16.78</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Unvested – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjadGico0lw3" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">914,792</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z55ok74lsmXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">13.07</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1Bs60GxPdzi" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6vjMhSjE8ed" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 525000 9.67 0 0 794235 16.27 108000 16.78 0 0 0 0 404443 13.70 108000 16.78 914792 13.07 0 0 14733972 9392782 8928327 6819929 10519323 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zeNrjih7LKAh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Based Awards (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zTWs5gFUTugf" style="display: none">Schedule of warrant activity</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Warrants</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Outstanding - December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20260101__20260630_zXjo6zIhFV44" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20260101__20260630_zn0tljTKeiJ" style="width: 13%; text-align: right" title="Weighted average exercise price warrants outstanding, beginning balance">9.70</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20260101__20260630_zcCjd8LKHYD9" style="text-align: right" title="Warrants granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zSmKA0MssfC8" style="text-align: right" title="Weighted average exercise price warrants, granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Forfeited/cancelled/restored</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_d0_c20260101__20260630_z8W71fPrRYyc" style="text-align: right" title="Warrants forfeited/cancelled/restored">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20260101__20260630_zbxWldhulOm4" style="text-align: right" title="Weighted average exercise price warrants, forfeited/cancelled/restored">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20260101__20260630_zMM1Si1wg8Ei" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised">(350,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue_c20260101__20260630_ztufO3O6bJJh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price warrants, exercised">9.70</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding – June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20260101__20260630_zRTF5W5VPMp2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20260101__20260630_zVcrs9cqImu7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 350000 9.70 0 0 0 0 350000 9.70 0 0 350000 3395000 <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zNoDvhnU62xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 11 – <span id="xdx_82A_zICIWaL1SuH2">Related Party Transactions</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 30, 2024 (“Grant Date”), the Company entered into a two-year Management Services Agreement (the “Agreement”) with 8 Consulting LLC (the “Consultant”) for the services of our Chief Executive Officer, Dr. Allan Evans. The Agreement allows Dr. Evans to receive favorable tax benefits as a resident of the Commonwealth of Puerto Rico who performs such services in Puerto Rico. Pursuant to the Agreement, Dr. Evans performs the duties and responsibilities that are customary for a chief executive officer of a public company similar to the Company. The Consultant received a $<span id="xdx_908_eus-gaap--ProfessionalAndContractServicesExpense_c20231204__20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrEvansMember_zfwCxKoqXNR7">250,000</span> fee per year, until October 2025 at which time it was increased to $<span id="xdx_908_eus-gaap--ProfessionalAndContractServicesExpense_c20251101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrEvansMember_z2DRDe5znsS3">300,000</span> per year, payable in monthly installments. On April 1, 2026, the Compensation Committee extended the Consultants contract through December 31, 2026 and increased the annual fee to $<span id="xdx_907_eus-gaap--ProfessionalAndContractServicesExpense_c20260401__20260402__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrEvansMember_zpBOw5cC1kxj">350,000</span>. See Note 13 - Subsequent Events.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2026, the Company issued <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector1Member_z5kaUrGH0ET6"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector2Member_zFNbp2hW0gNf"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20260312__20260313__srt--CounterpartyNameAxis__custom--IndependentDirector3Member_z5iLBIyXpBu5" title="Vested shares">1,961</span></span></span> vested shares of common stock to each of three of its independent directors as compensation for the first quarter 2026; the fourth independent director elected to receive cash compensation. The shares were valued at an aggregate of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20260312__20260313_zYBEN5YkINCe" title="Shares aggregate value">120,013</span> and were immediately recognized as stock compensation expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2026, the Company paid $<span id="xdx_90B_eus-gaap--RepaymentsOfRelatedPartyDebt_c20260330__20260402__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CEOAndTwoIndependentDirectorsMember_zP4hx7v4E7Uh" title="Payments for related party">217,943</span> to its investment committee, which includes the Chief Executive Officer and two independent Directors of the Company. The payment is based on a <span id="xdx_908_eus-gaap--RelatedPartyTransactionRate_dp_c20260330__20260402__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CEOAndTwoIndependentDirectorsMember_zlrJCz25qexc" title="Committee member interest rate">1</span>% per committee member based on the realized gains from investments during the previous quarter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2026, the Company received a $<span id="xdx_907_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn5n6_c20260101__20260131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_z6Z6naN1gSOg" title="Received order from related party">2.1</span> million order in addition to several smaller orders from Teal Drones, which is a subsidiary of Red Cat. Red Cat is a related party as Jeff Thompson is the Chief Executive Officer of Red Cat and is also on the Board of Directors of Unusual Machines. The order was delivered in the first half of 2026 and includes several different drone components manufactured and sourced from the Company. The Company recognized approximately $<span id="xdx_900_eus-gaap--Revenues_pn5n6_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_zC9KDFTIGWpc" title="Revenue">2.2</span> million in revenue from this related party for the six months ended June 30, 2026. The Company had related party receivables of $<span id="xdx_901_eus-gaap--ContractWithCustomerLiability_iI_pn5n6_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TealDronesMember_z836mvXpURC5" title="Related party receivables">1.3</span> million as of June 30, 2026</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 250000 300000 350000 1961 1961 1961 120013 217943 0.01 2100000 2200000 1300000 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zIfH3Sx6VLpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 12 – <span id="xdx_823_zwu7e1OO7zP8">Commitments and Contingencies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20240213__20240214__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WarehouseAndOfficeSpaceMember_zyHIgP17Z2fi" title="Lease description">As part of the business combination that occurred on February 14, 2024, the Company acquired a five-year operating lease for approximately 6,900 square feet of warehouse and office space in Orlando, Florida. The lease commenced in November 2023 and expires in October 2028.</span> See Note 7 – Operating Leases for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90A_eus-gaap--LesseeOperatingLeaseDescription_c20250603__20250604__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DroneMotorManufacturingFacilityMember_zU3ND9nbGcR5" title="Lease description">On June 4, 2025, the Company entered into a five -year operating lease agreement for approximately 17,000 square feet of space for the Company’s drone motor manufacturing facility in Orlando, Florida. The lease commenced on August 1, 2025 and expires in August 2030.</span> See Note 7 – Operating Leases for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a part of the business combination that occurred on September 3, 2025 with Rotor Lab, the Company acquired a three-year operating lease of warehouse and office space in Canberra Australia. The lease commenced in May 2024 and expires in April 2027. See Note 7 – Operating Leases for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90D_eus-gaap--LesseeOperatingLeaseDescription_c20251029__20251030__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceMember_zWEDjZBbTVhh" title="Lease description">On October 30, 2025, the Company entered into a five-year operating lease agreement for an additional 25,000 square feet of warehouse/office space in Orlando, FL. The lease commencement date is December 1, 2025 and expires in December 2030.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90F_eus-gaap--LesseeOperatingLeaseDescription_c20251209__20251210__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--CorporateHeadquartersMember_zMwP3U96D916" title="Lease description">On December 10, 2025, the Company entered into a three-year operating lease agreement for an additional 9,125 square feet of space in Orlando, FL. This space will be used as the Company’s corporate headquarters. The lease commenced on February 1, 2026 and expires in February 2029.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_905_eus-gaap--LesseeOperatingLeaseDescription_c20251214__20251215__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--HeadsetProductionMember_zbtyXxUJanmb" title="Lease description">On December 15, 2025, the Company entered into a three-year operating lease agreement for an additional 4,500 square feet of space in Orlando, FL. This space will be used for headset production. The lease commenced on January 1, 2026 and expires in December 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> As part of the business combination that occurred on February 14, 2024, the Company acquired a five-year operating lease for approximately 6,900 square feet of warehouse and office space in Orlando, Florida. The lease commenced in November 2023 and expires in October 2028. On June 4, 2025, the Company entered into a five -year operating lease agreement for approximately 17,000 square feet of space for the Company’s drone motor manufacturing facility in Orlando, Florida. The lease commenced on August 1, 2025 and expires in August 2030. On October 30, 2025, the Company entered into a five-year operating lease agreement for an additional 25,000 square feet of warehouse/office space in Orlando, FL. The lease commencement date is December 1, 2025 and expires in December 2030. On December 10, 2025, the Company entered into a three-year operating lease agreement for an additional 9,125 square feet of space in Orlando, FL. This space will be used as the Company’s corporate headquarters. The lease commenced on February 1, 2026 and expires in February 2029. On December 15, 2025, the Company entered into a three-year operating lease agreement for an additional 4,500 square feet of space in Orlando, FL. This space will be used for headset production. The lease commenced on January 1, 2026 and expires in December 2028. <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zemVV0JVFAn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Note 13 – <span id="xdx_82D_zeAIq8w79HIa">Subsequent Events</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Equity Grants</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2026, the Compensation Committee granted 5,000,000 of unvested five-year warrants to the Company’s Chief Executive Officer. The warrants have exercise price at $25 per share. The closing price of the Company’s common stock on the grant date was $19.36. The warrants will vest in increments of 1,000,000 shares upon any 20-day average closing price of the Company’s common stock at each of the following tranches: $25, $40, $60, $80 and $100. The Company will seek to obtain stockholder approval as required by the NYSE American.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2026 the Compensation Committee granted a total of 1,275,000 five-year stock options, exercisable at $19.36 per share, the closing price of the Company’s stock on the grant date, to the Company’s three other executive officers in increments of 375,000, 375,000 and 525,000 stock options, respectively. The stock options vest quarterly over a three-year period subject to each person, as applicable, remaining to be employed by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2026, the Company granted approximately 1.6 million five-year stock options, exercisable at $19.36 per share, the closing price of the Company’s stock on the grant date, to specific employees. The options vest over four years of continued service with the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Leases</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2026, the Company entered into a three-year operating lease agreement for an additional 14,000 square feet of space in Orlando, FL. This space will be used for battery production. The lease commenced on August 1, 2026 and expires in December 2028.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 23, 2026, the Company entered into a lease amendment related to its corporate headquarters in Orlando, FL. The amendment increases the existing space from 9,125 square feet to a total of 19,389. In addition, the original lease term was extended from March 31, 2029 to December 31, 2031. The Company anticipates the additional space to commence on September 1, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> false false false Chief Executive Officer true March 16, 2026